WO2021033722A1 - Method for producing habituated cells, method for managing habituated cells, device for managing habituated cells, and computer program - Google Patents

Method for producing habituated cells, method for managing habituated cells, device for managing habituated cells, and computer program Download PDF

Info

Publication number
WO2021033722A1
WO2021033722A1 PCT/JP2020/031310 JP2020031310W WO2021033722A1 WO 2021033722 A1 WO2021033722 A1 WO 2021033722A1 JP 2020031310 W JP2020031310 W JP 2020031310W WO 2021033722 A1 WO2021033722 A1 WO 2021033722A1
Authority
WO
WIPO (PCT)
Prior art keywords
pluripotent stem
information
acclimation
cell
acclimated
Prior art date
Application number
PCT/JP2020/031310
Other languages
French (fr)
Japanese (ja)
Inventor
亮介 高橋
剛 内田
清太 中村
育恵 三谷
俊輔 上田
Original Assignee
昭和電工マテリアルズ株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 昭和電工マテリアルズ株式会社 filed Critical 昭和電工マテリアルズ株式会社
Publication of WO2021033722A1 publication Critical patent/WO2021033722A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor

Definitions

  • the present disclosure relates to a method for producing acclimated cells, a method for managing acclimated cells, an acclimatized cell management device, and a computer program.
  • Embryonic stem cells ES cells
  • iPS cells inducible pluripotent stem cells
  • pluripotent stem cells retain the ability to differentiate into other cell lines and can differentiate into cells of the desired stage under various conditions. Taking advantage of this property, the use of pluripotent stem cells is increasing in many fields such as cell differentiation research, disease treatment application, and drug screening.
  • a cell scaffold material formed of an adhesive substrate material is used, but in order to obtain a larger amount in a smaller space, a suspension culture that does not require a cell scaffold material is used. It has been proposed (eg, WO2011 / 058558, US901801, etc.).
  • An object of the present disclosure is to provide a method for producing acclimated cells to obtain pluripotent stem cells acclimated to suspension culture while saving time and effort.
  • it is necessary to appropriately manage the acclimation process by acquiring various information such as information on the pluripotent stem cells to be subjected to the acclimation process, information on the acclimated pluripotent stem cells, and information on the acclimation process itself.
  • acclimation cell production methods, acclimation cell management methods, acclimation cell management devices, and computer programs that can provide additional value in providing acclimated pluripotent stem cells to customers. Another purpose is to provide.
  • the present disclosure provides the following aspects.
  • the method for producing acclimated cells enables the reception of flat-cultured pluripotent stem cells from a supplier and the transition of the received pluripotent stem cells from flat culture to suspension culture.
  • the pluripotent stem cells received by the acclimation treatment are subjected to primary acclimation culture in a primary acclimation culture vessel filled with a primary acclimation medium, and the primary acclimation has been performed.
  • the primary acclimation treatment to obtain pluripotent stem cells and the suspension culture of the primary acclimated pluripotent stem cells in a suspension culture container filled with a secondary acclimation medium were performed, and the secondary acclimated polyplasia was acclimated to the suspension culture. Includes a secondary acclimation process to obtain capable stem cells.
  • the method for producing acclimated cells includes initial cell information regarding the pluripotent stem cells before being subjected to the acclimation treatment, primary acclimation processing information regarding the primary acclimation treatment, and secondary acclimation treatment. Selected from the group consisting of acclimation processing information, primary acclimated pluripotent stem cell information on the primary acclimated pluripotent stem cell, and secondary acclimated pluripotent stem cell information on the secondary acclimated pluripotent stem cell. Further including obtaining at least one piece of information.
  • the initial cell information includes at least information on the cell type of the pluripotent stem cell before being subjected to the acclimation treatment.
  • the primary acclimation treatment information includes at least information on the primary acclimation medium and information on culture conditions related to the primary acclimation treatment.
  • the secondary acclimation treatment information includes at least information on the secondary acclimation medium and information on suspension culture conditions related to the secondary acclimation treatment.
  • the primary conditioned pluripotent stem cell information includes at least information on the number of cells of the primary conditioned pluripotent stem cells and the characteristics of cell morphology
  • the secondary The conditioned pluripotent stem cell information includes at least information on the cell number of the secondary conditioned pluripotent stem cells and the characteristics of cell morphology.
  • the method for producing acclimated cells includes the initial cell information, the primary acclimation processing information, the secondary acclimation processing information, the primary acclimated pluripotent stem cell information, and the secondary acclimated pluripotency. Further comprising providing the provider with at least one obtained information selected from the group consisting of stem cell information.
  • the acclimated pluripotent stem cells are provided to the donor in a suspended culture form.
  • the acclimation cell management method is a acclimation cell management method executed by at least one processor that executes a computer-readable instruction, and the at least one processor executes the instruction.
  • the initial cell information regarding the planar cultured pluripotent stem cells is acquired and stored, and the acclimatization processing information regarding the acclimatization process for enabling the transition from the planar culture to the suspension culture for the pluripotent stem cells is performed.
  • the acclimatized pluripotent stem cell information regarding the acclimatized pluripotent stem cells generated by the acclimatization process is acquired and stored.
  • the at least one processor executes the instruction to further provide the acclimated pluripotent stem cell to the destination to which the acclimated pluripotent stem cell is provided.
  • the donor request information regarding the request for the sex stem cell is acquired and stored in advance, and the donor request information is compared with the acclimatized pluripotent stem cell information to determine whether or not there is a difference between the two.
  • the at least one processor further obtains the initial cell information, the acclimation processing information, and the acclimated pluripotent stem cell information by executing the instruction. At least one piece of information selected from the group is transmitted to the destination server device to which the acclimatized pluripotent stem cells are provided via a communication line.
  • the initial cell information, the acclimation processing information, and the acclimated pluripotent stem cell information are acquired from the acclimation processing device that executes the acclimation processing via a communication line. Will be done.
  • the provision destination request information is acquired from the provision destination server device of the provision destination via a communication line.
  • the pluripotent stem cells are subjected to primary acclimation culture in a primary acclimation culture vessel filled with a primary acclimation medium, and the primary acclimated pluripotency is performed.
  • the primary acclimation treatment for obtaining sex stem cells and the suspension culture of the primary acclimated pluripotent stem cells in a suspension culture container filled with a secondary acclimation medium are performed, and the secondary acclimated pluripotency acclimated to the suspension culture is performed.
  • the acclimation processing information includes the primary acclimation processing information regarding the primary acclimation process and the secondary acclimation processing information regarding the secondary acclimation process, and includes the secondary acclimation process for obtaining sex stem cells.
  • the stem cell information includes the primary acclimated pluripotent stem cell information regarding the primary conditioned pluripotent stem cell and the secondary conditioned pluripotent stem cell information regarding the secondary conditioned pluripotent stem cell.
  • the initial cell information includes at least information on the cell type of the pluripotent stem cell.
  • the primary acclimation treatment information includes at least information on the primary acclimation medium and information on culture conditions related to the primary acclimation treatment.
  • the secondary acclimation processing information includes at least information on the secondary acclimation medium and information on suspension culture information on the secondary acclimation treatment.
  • the primary conditioned pluripotent stem cell information includes at least information on the number of cells of the primary conditioned pluripotent stem cell and the characteristics of cell morphology
  • the secondary The conditioned pluripotent stem cell information includes at least information on the cell number of the secondary conditioned pluripotent stem cells and the characteristics of cell morphology.
  • the acclimated cell management apparatus includes one or a plurality of processors, and the processors acquire and store initial cell information regarding plane-cultured pluripotent stem cells, and the pluripotent stem cells.
  • the acclimation process information related to the acclimation process for performing the acclimation process to enable the transition from the planar culture to the suspension culture is acquired and stored, and the acclimated pluripotent stem cells generated by the acclimatization process have been acclimatized.
  • the at least one processor is made to function so as to acquire and store pluripotent stem cell information.
  • the acclimated cell management device acquires and stores in advance destination request information regarding a request for the acclimated pluripotent stem cell of the destination to which the acclimated pluripotent stem cell is provided.
  • the at least one processor is further functionalized to compare the destination request information with the acclimatized pluripotent stem cell information to determine if there is a difference between the two.
  • the acclimatized cell management device transmits at least one information selected from the group consisting of the initial cell information, the acclimatization processing information, and the acclimatized pluripotent stem cell information via a communication line.
  • the at least one processor is further functionalized to transmit the conditioned pluripotent stem cells to a destination server device to which the cells are provided.
  • the initial cell information, the acclimation processing information, and the acclimated pluripotent stem cell information are acquired from the acclimation processing device that executes the acclimation processing via a communication line. Will be done.
  • the provision destination request information is acquired from the provision destination server device of the provision destination via a communication line.
  • the computer program acquires and stores initial cell information about pluripotent stem cells cultured in a plane by being executed by at least one processor, and planes the pluripotent stem cells. Performs acclimation processing to enable the transition from culture to suspension culture Acquires and stores acclimation processing information related to the acclimation process, and acclimatized pluripotent stem cells related to the acclimated pluripotent stem cells generated by the acclimation process.
  • the at least one processor is made to function so as to acquire and store information.
  • the computer program acquires, stores, and stores in advance the destination request information regarding the request for the conditioned pluripotent stem cell of the destination to which the conditioned pluripotent stem cell is provided, and provides the provided information.
  • the at least one processor is further functionalized to compare the prior demand information with the acclimated pluripotent stem cell information to determine if there is a difference between the two.
  • the computer program obtains at least one piece of information selected from the group consisting of the initial cell information, the acclimatization processing information, and the acclimatized pluripotent stem cell information via a communication line.
  • the at least one processor is further functionalized such that the conditioned pluripotent stem cells transmit to the destination server device of the destination to which they are provided.
  • the initial cell information, the acclimation processing information, and the acclimated pluripotent stem cell information are acquired from the acclimation processing device that executes the acclimation processing via a communication line. ..
  • the provision destination request information is acquired from the provision destination server device of the provision destination via a communication line.
  • the acclimatization process is performed by acquiring various information such as information on the pluripotent stem cells to be subjected to the acclimatization process, information on the acclimatized pluripotent stem cells, and information on the acclimatization process itself.
  • Providing acclimation cell management methods, acclimation cell management devices, and computer programs that can be properly managed and also provide additional value in providing acclimated pluripotent stem cells to customers. can do.
  • FIG. 1 It is a block diagram which shows an example of the structure of the management system including the acclimatization cell management apparatus which concerns on one Embodiment. It is a block diagram which shows typically an example of the function of the acclimation cell management apparatus shown in FIG. It is a block diagram which shows typically an example of the function of the acclimatization processing apparatus shown in FIG.
  • the numerical range indicated by using “-” indicates a range including the numerical values before and after "-" as the minimum value and the maximum value, respectively.
  • the content of each component in the composition is the total amount of the plurality of substances present in the composition unless otherwise specified, when a plurality of substances corresponding to each component are present in the composition. Means.
  • the term "process” is included in the term not only in an independent process but also in the case where the desired action of the process is achieved even if it cannot be clearly distinguished from other processes.
  • the method for producing acclimated cells is to receive the pluripotent stem cells cultured in a plane from a supplier (hereinafter referred to as a receiving step), and to suspend the received pluripotent stem cells from a plane culture.
  • a receiving step Performing an acclimatization treatment to enable the transition to (hereinafter referred to as an acclimatization step), obtaining pluripotent stem cells acclimatized to suspension culture by the acclimatization treatment, and the obtained pluripotent pluripotency It includes providing stem cells to a designated donation destination (hereinafter referred to as a donation step) in response to a request from the donation destination.
  • a donation step a designated donation destination
  • the pluripotent stem cells cultured in a plane are obtained from a supplier.
  • the acclimated pluripotent stem cells obtained by subjecting the obtained pluripotent stem cells to a specific acclimation treatment are provided to a designated donor in response to a request from the donor. Therefore, the donor can obtain the pluripotent stem cells that have been acclimatized to the suspension culture when they are requested without the need for acclimatization treatment.
  • the supply source and the supply destination may be the same or different.
  • the description of "provider” may be read as “supply source”, and in some cases, may be read as both "provider” and "supply source”.
  • the acclimation process is carried out at a place, institution, etc. different from the supply source and the supply destination.
  • a place, an institution, etc. that performs habituation processing may be referred to as a "habituation executing agency" for convenience.
  • the culture medium may be simply referred to as "medium”.
  • the method for producing the acclimated cells will be described.
  • the flat-cultured pluripotent stem cells are received from the supplier.
  • the “pluripotent stem cell” is not limited as long as it is an undifferentiated cell having the ability to differentiate into a plurality of cells and self-renewal ability, and is an embryonic stem cell (ES cell) or an inducible pluripotent stem cell. (IPS cells), mesenchymal stem cells (MSCs), Muse cells and the like can be mentioned, and among them, ES cells and iPS cells capable of differentiating into all three embryonic lineages of endometrial, mesenchymal and ectodermal can be used. ..
  • the origin of these pluripotent stem cells is not particularly limited, and examples thereof include humans, monkeys, mice, rats, pigs, and dogs.
  • the pluripotent stem cells obtained in the receiving step are plane-cultured.
  • the planar culture is also referred to as two-dimensional culture in some cases, and refers to a culture method in which cells are adhered and cultured on the culture surface of a culture vessel having a flat surface.
  • the plane that becomes the culture surface of the culture vessel is a cell of a cell-affinitive polymer, a cell layer of a feeder cell, an extracellular matrix such as vitronectin, fibronectin, collagen, Matrigel (registered trademark, hereinafter omitted), or a partial peptide thereof. It may be provided as a scaffolding material.
  • the medium used for the planar culture can be appropriately selected depending on the type of pluripotent stem cells to be targeted, and examples thereof include DMEM or DMEM-F12 containing 10% (v / v) FBS.
  • the culture conditions for the planar culture may be any conditions normally applied to the target pluripotent stem cells, and can be, for example, a temperature condition of 37 ° C. and a 10% CO 2 environment.
  • the culture conditions can be appropriately changed according to the state of the cells as long as the differentiation stage of the cells does not change.
  • any form can be provided as long as the cells can be transferred, and examples thereof include a liquid culture form and a cryopreservation form.
  • Pluripotent stem cells may be transferred from the source to the acclimatization agency.
  • a transfer form such as a constant temperature transfer, a refrigerated transfer, a frozen transfer, or the like may be appropriately selected according to the form of provision from the supplier.
  • the received pluripotent stem cells are acclimated to enable the transition from planar culture to suspension culture.
  • the term "suspended culture” refers to a culture method in which cells are suspended and cultured in a medium rather than being adhered to a flat surface.
  • the acclimatization treatment refers to a culture medium in which pluripotent stem cells adapted to a static growth environment that grows by adhering to a plane that becomes a two-dimensional environment are used as a three-dimensional environment. It is a process of gradually "acclimating" cells to a floating environment in which cells are dispersed and grow in the system.
  • the cells may be dispersed in the medium as a single cell, a plurality of cells may accumulate to form a spheroid, and the cells adhere to microcarriers such as microbeads to which they can adhere. It may be in a state or may have periods of these different states during the acclimatization process.
  • a plurality of media may be used for the acclimation treatment, and the culture conditions such as the culture temperature, pH, and stirring of the medium may be changed.
  • cells can be maintained and increased by repeating the passage at a predetermined timing so as to maintain an appropriate number of cells according to the state of the cells.
  • the culture can be carried out under a temperature condition of, for example, 37 ° C. and in a 10% CO 2 environment.
  • the received pluripotent stem cells are further subjected to primary acclimatization culture in a primary acclimatization culture vessel filled with a primary acclimatization medium to obtain primary acclimatized pluripotent stem cells (hereinafter, primary acclimatization treatment). ),
  • the primary acclimated pluripotent stem cells are subjected to suspension culture in a suspension culture container filled with a secondary acclimation medium (hereinafter referred to as secondary acclimation treatment), and the secondary acclimation medium is used for suspension culture. It can include obtaining secondary conditioned pluripotent stem cells.
  • a primary acclimation medium and a primary acclimation culture container are used for the primary acclimation treatment.
  • the primary acclimation medium and the primary acclimation culture vessel used in the primary acclimation treatment may be at least one different from the medium or culture vessel used in the plane culture before receiving the pluripotent stem cells.
  • pluripotent stem cells can be provided in a culture environment different from that of the planar culture before receipt.
  • the primary acclimation treatment if at least one of the medium and the culture vessel is different from the culture conditions of the plane culture or the secondary acclimation treatment before receiving the cells, the plane culture stage and the floating under the conditions different from the secondary acclimation treatment.
  • At least one stage with the culture stage can be included, and both the plane culture stage and the suspension culture stage can be included.
  • the primary acclimation process a multi-step primary acclimation process consisting of two stages, a plane culture stage and a suspension culture stage, it is possible to perform cell acclimation gently with less stress due to acclimation, and the cells float more efficiently. Pluripotent stem cells acclimated to culture can be obtained.
  • the culture conditions at the plane culture stage in the primary acclimatization treatment may be the same as or different from the plane culture performed on the received pluripotent stem cells.
  • Examples of the culture conditions referred to here include the medium to be used, the culture vessel, temperature, pH and the like.
  • extracellular matrix such as Matrigel and cell scaffold material such as mouse embryonic fibroblast (MEF) may be used on the culture surface, and Matrigel having no heterologous component may be used. Can be used.
  • a medium different from the planar culture performed on the received pluripotent stem cells can be used.
  • a medium containing DMEM-F12 containing human basic fibroblast growth factor (bFGF), TGF ⁇ 1, GABA, bovine serum albumin (BSA), cholesterol, etc. is used for the plane culture stage. It can be used as a medium.
  • bFGF human basic fibroblast growth factor
  • BSA bovine serum albumin
  • the plane culture step can be completed when the number of cells reaches a predetermined number, for example, about 1 ⁇ 10 6 to 3 ⁇ 10 6.
  • the cells in the plane culture can be recovered by enzyme treatment such as trypsin and can be transferred to the suspension culture stage.
  • culture conditions that facilitate suspension culture of pluripotent stem cells for example, selection of a medium having a composition that facilitates suspension culture of pluripotent stem cells, removal of cell scaffold material, a combination thereof, etc. are selected. can do.
  • the pluripotent stem cells that have been cultivated in a plane are subjected to suspension culture.
  • Examples of the culture medium for the suspension culture stage having a composition that facilitates suspension culture of pluripotent stem cells include 1 to 50% (v / v) or 5 to 30% (v / v) knockout serum substitute, 1 to 150 ng /.
  • the suspension culture step in the primary acclimation treatment can be static suspension culture.
  • the culture vessel used in the static suspension culture step include a dish having no cell scaffolding material such as a matrix such as Matrigel or a mouse embryonic fibroblast layer.
  • the suspension culture step in the primary acclimation process can be continued until the pluripotent stem cells enter the logarithmic growth phase in which they proliferate in an undifferentiated state. Although it depends on the state of cells, it can generally be about 1 to 2 months. Pellets of pluripotent stem cells in suspension culture or isolated pluripotent stem cell clusters can be dissociated by pipetting the cells up and down in a small amount (eg, 0.2-1 mL) of medium. it can. As a result, pluripotent stem cells in the suspension culture stage can be efficiently obtained in large quantities.
  • the primary acclimation treatment step is terminated and the process proceeds to the secondary acclimation step.
  • the primary acclimation step primary acclimated pluripotent stem cells can be obtained.
  • the primary acclimated pluripotent stem cells are suspended-cultured in a suspension culture container filled with a secondary acclimation medium.
  • the medium for secondary acclimation used in the secondary acclimation step can be different from the medium in the suspension culture stage in the primary acclimation step. Specifically, it is possible to select a medium having a composition that enhances the tendency for suspension culture to be more likely for the primary conditioned pluripotent stem cells.
  • Examples of the medium for secondary acclimation include a medium containing a protease inhibitor.
  • the protease inhibitor those described later can be used.
  • Mediums containing protease inhibitors can contain naturally occurring components.
  • a limited medium containing the protease inhibitor may be used.
  • the term "limited medium” means a culture medium that is artificial and whose components are all known.
  • the medium can be an aqueous medium containing a combination of substances such as salts, nutrients, minerals, vitamins, antibiotics, amino acids, nucleic acids, and proteins.
  • various additives described in the specification can be added to a synthetic tissue culture medium such as DMEM-F12.
  • protease inhibitor examples include a reversible protease inhibitor and an irreversible protease inhibitor, and a reversible protease inhibitor and an irreversible protease inhibitor of serine protease.
  • Reversible inhibitors of serine proteases include phenylmethylsulfonylfluoride (PMSF), GSK3 ⁇ inhibitors, aldehyde-CHO, arylketone- CO-aryl, trifluoromethylketone-COCF 3 , ketocarboxylic acid-COCOOH and the like. ..
  • concentration of PMSF used can be 0.01 mM to 1 mM in the medium.
  • Irreversible inhibitors of serine proteases include trypsin and trypsin-like serine proteases, including tosyl-L-lysyl-chloromethanehydrochloride (TLCK).
  • TLCK (CAS 4238-41-9) is an irreversible inhibitor of trypsin and trypsin-like serine proteases.
  • concentration of TLCK used can be 0.05 ⁇ M to 1000 ⁇ M in the medium, for example, 5 ⁇ M to 100 ⁇ M.
  • the medium for secondary acclimation can further contain a GSK3 ⁇ inhibitor such as CHIR99021, a WNT3A polypeptide, a stabilizer for WNT3A, a leukemia inhibitory factor (LIF), an IL6RIL6 chimera and the like.
  • the medium for secondary acclimation can be free of ERK1 / 2 inhibitors, JNK inhibitors, p38 inhibitors, basic fibroblast growth factor (bFGF) and the like.
  • the secondary acclimation medium can be serum-free and can include 1-50% (v / v) or 5-30% (v / v) knockout serum substitutes. Examples of such a secondary acclimation medium include the limited culture medium described in International Publication No.
  • Examples of the medium for secondary acclimation include Essential 8 (Thermo Fisher), mTeSR1 (STEMCELL Technologies), StemFit series (Takara Bio Inc.), StemFlex (Thermo Fisher Scientific), and the like, in addition to those described above. it can.
  • the suspension culture in the secondary acclimation step can be a dynamic suspension culture in order to expand the number of cells more efficiently.
  • the suspension culture container used for dynamic suspension culture is particularly limited as long as it has a volume and equipment capable of dispersing the cells in culture in the medium at an appropriate speed, shearing force, and dispersion degree.
  • Spinna Plasco and the like can be mentioned.
  • the medium used in the suspension culture stage of the primary acclimation treatment can be switched to the secondary acclimation medium in several stages of two or more stages so as to gradually increase the proportion of the secondary acclimation medium.
  • the culture vessel may be changed from a culture vessel suitable for static suspension culture to a culture vessel suitable for dynamic suspension culture at a timing according to the cell growth state in accordance with the change in the composition of the medium.
  • the primary conditioned cells can be gently applied to the secondary conditioned environment, and as a result, the number of cells can be efficiently expanded.
  • the secondary acclimation step may be continued while grasping the state of the cells while exchanging the medium and confirming that the cells are in an undifferentiated state.
  • Pellets of pluripotent stem cells in suspension culture or isolated pluripotent stem cell clusters can be dissociated by pipetting the cells up and down in a small amount (eg, 0.2-1 mL) of medium. it can.
  • pluripotent stem cells in suspension culture can be efficiently obtained in large quantities.
  • secondary acclimated pluripotent stem cells acclimated to suspension culture can be obtained.
  • the undifferentiated state of the secondary conditioned pluripotent stem cells can be confirmed by appearance, cell surface antigen, expression marker and the like.
  • Being undifferentiated is a known feature that confirms the undifferentiated state of pluripotent stem cells, such as at least 2 of markers such as OCT4, Nanog, Tra-1-60, Tra-1-81, SSEA4, SOX2. It can be confirmed in one or more expression states.
  • the obtained acclimatized pluripotent stem cells are provided by the acclimatization executing agency to the designated donor in response to a request from the donor.
  • the provider may be the same as or different from the supplier, and therefore the offer may be in response to a request from the supplier or a request from the supplier. May be good.
  • Examples of the form of provision include the following forms: (1) A form in which acclimatized pluripotent stem cells derived from pluripotent stem cells received from the supplier are provided to the supplier in response to a request from the supplier, that is, when the supplier requires it. (2) The conditioned pluripotent stem cells derived from the pluripotent stem cells received from the supplier are sent to a different destination from the supplier in response to a request from the supplier, that is, when the supplier requires it. Form to provide, (3) A form in which the conditioned pluripotent stem cells derived from the pluripotent stem cells received from the supplier are provided to the donor in response to a request from the donor, that is, when the donor requires it.
  • the acclimatized pluripotent stem cells provided to the recipient may be provided in a suspension culture form, or may be isolated from the suspension culture form and provided, for example, in a cryopreserved form.
  • the acclimatized pluripotent stem cells can be collected from the suspension culture system and then filled in a supply container together with a predetermined medium.
  • the container for provision may be a hard container such as a bottle or a soft container such as a bag. Examples of such a container for provision include a bioreactor for cell culture.
  • the bioreactor for cell culture may be a reusable one, or may be a so-called single-use bioreactor.
  • Pluripotent stem cells can be transferred from the acclimatization executing agency to the delivery destination.
  • a transfer form such as a constant temperature transfer, a refrigerated transfer, a frozen transfer, or the like may be appropriately selected according to the supply form.
  • the supplier or the provider using the pluripotent stem cells acclimated to the suspended cells does not have to take the trouble of carrying out the steps from the planar culture to the suspended culture by themselves.
  • Pluripotent stem cells acclimated to can be obtained.
  • pluripotent stem cells acclimatized to floating cells can be maintained like a "fish cage” and easily prepared with the required number of cells when needed.
  • the source or destination of cells is the customer, it is not necessary for the customer to prepare the acclimated pluripotent stem cells, and the number of cells acclimated to the suspension culture is increased when the customer needs it. It is possible to provide pluripotent stem cells.
  • the obtained pluripotent stem cells acclimated to the suspension culture can maintain undifferentiated ability and proliferate efficiently, they can be used in various modes as convenient pluripotent stem cells for the recipient. be able to. Examples of such utilization include utilizing the undifferentiated ability of the acclimatized pluripotent stem cells to induce differentiation into desired cells, and using the cells for screening of drugs and the like.
  • an identification ID for distinguishing them from other pluripotent stem cells such as an identification tag, an individual chip, a process control number, and a barcode is assigned. You may. By assigning the identification ID, individual management can be performed from the receiving process to the acclimatization step and the provision process until the acclimatized pluripotent stem cells are provided to the recipient.
  • the acclimation process can be performed while monitoring the number of cells (acquiring information on the number of cells).
  • the primary acclimation culture and the secondary acclimation culture can be performed so as to have a predetermined number of cells.
  • the acclimatized cells can be maintained and proliferated while subcultured.
  • the number of cells can be easily monitored, for example, by considering the doubling time of cells and adjusting the number of cells to a certain number at the time of medium exchange and seeding.
  • information on the number of cells is used as an example, information on pluripotent stem cells to be subjected to acclimation treatment, information on acclimated pluripotent stem cells (acclimated pluripotent stem cells), and acclimation treatment.
  • information on pluripotent stem cells to be subjected to acclimation treatment information on pluripotent stem cells to be subjected to acclimation treatment
  • information on acclimated pluripotent stem cells acclimated pluripotent stem cells
  • acclimation treatment acclimation treatment.
  • Various information related to the acclimatization process such as the information itself can be acquired. Details such as acquisition of various information will be described later.
  • the method for producing acclimated cells according to the present disclosure has been described as the cells received from the supplier as pluripotent stem cells cultured in a plane, the cells received from the supplier are not limited to pluripotent stem cells.
  • Another aspect of the disclosure may include receiving plane-cultured somatic cells from a source.
  • the cells after receiving the cells from the source, the cells are reprogrammed according to a known method, and the pluripotent stem cells obtained by the reprogramming can be transferred from the planar culture to the suspension culture. It may include performing acclimatization processing for the purpose.
  • FIG. 1 is a block diagram showing an example of the configuration of the management system 1 including the acclimation cell management device 100 according to the embodiment.
  • FIG. 2 is a block diagram schematically showing an example of the function of the conditioned cell management device 100 shown in FIG.
  • FIG. 3 is a block diagram schematically showing an example of the function of the acclimation processing device 200 shown in FIG.
  • the term application may be referred to as software or program, and is a command to a computer, which is combined so as to obtain a certain result. All you need is.
  • the management system 1 is mainly composed of the acclimation cell management device 100 and the acclimation processing device 200.
  • the acclimation cell management device 100 and the acclimation processing device 200 can transmit and receive various electronic information via a communication line.
  • the acclimatization cell management device 100 may be capable of transmitting and receiving various electronic information via a communication line with one or a plurality of destination server devices 300.
  • FIG. 1 as an example, it is assumed that there are three providing destinations, and the providing destination server device 300 (providing destination server device 300A, providing destination server device 300B, each of the three providing destinations). And is connected to the provider server device 300C) via a communication line.
  • the details of the acclimation cell management device 100 and the acclimation processing device 200 constituting the management system 1 will be described.
  • the acclimation cell management device 100 is a terminal device or a server device connected to the acclimation processing device 200 via a communication line.
  • the conditioned cell management device 100 may be one terminal device or server device, or may be composed of a plurality of terminal devices or server devices for the purpose of distributing the load.
  • the acclimatized cell management device 100 as a terminal device or a server device is a central processing unit, a main storage device, an input / output interface, an input device, an auxiliary storage device, which are connected to each other by a data bus and / or a control bus as hardware. , An output device, etc., and can execute various information processing described later.
  • the central processing unit is called a "CPU", and can perform calculations on instructions and data stored in the main storage device, and store the results of the calculations in the main storage device. Further, the central processing unit can control an input device, an auxiliary storage device, an output device, and the like via an input / output interface.
  • the conditioned cell management device 100 can include one or more central processing units.
  • the main storage device is called a "memory" and can store commands and data received via an input device, an auxiliary storage device, and an input / output interface, as well as calculation results of a central processing unit.
  • the main storage device may include, without limitation, RAM (random access memory), ROM (read-only memory) and / or flash memory and the like.
  • the auxiliary storage device is a storage device having a larger capacity than the main storage device.
  • the auxiliary storage device can store instructions and data (computer programs) that constitute a specific application, specifically, an acclimation cell management application, a web browser application, and the like. Further, the auxiliary storage device can transmit these instructions and data (computer program) to the main storage device via the input / output interface by being controlled by the central processing unit.
  • the auxiliary storage device may include, but is not limited to, a magnetic disk device and / or an optical disk device and the like.
  • the input device is a device that takes in data from the outside, and can include a touch panel, a button, a keyboard, a mouse, and / or a sensor without limitation.
  • the output device can include, without limitation, a display device, a touch panel and / or a printer device, and the like.
  • the central processing unit sequentially loads the instructions and data (computer programs) that make up a specific application stored in the auxiliary storage device into the main storage device, and the loaded instructions and data. Can be calculated. Thereby, the central processing unit controls the output device via the input / output interface, or also via the input / output interface and the communication line, the acclimation processing unit 200, and in some cases one or more destination servers. Various information can be transmitted and received to and from the device 300.
  • a specific application for acquiring various information related to the acclimatization process (for example, the above-mentioned acclimatization cell management application) is installed in the acclimatization cell management device 100.
  • the acclimatization cell management device 100 can acquire various information related to the acclimatization process by executing the application.
  • the acclimation cell management device 100 having the above-mentioned hardware configuration can mainly include the first communication unit 110 and the storage unit 120. Further, when the acclimatized cell management device 100 is connected to one or a plurality of destination server devices 300 via a communication line, the determination unit 130 can be further included. Furthermore, when the acclimatization cell management device 100 is a terminal device in particular, the display unit 140 and the first user interface unit 150 can be further included.
  • the first communication unit 110 is at least one selected from a group consisting of various information including initial cell information, acclimation processing information, and acclimated pluripotent stem cell information from the acclimation processing device 200 via a communication line.
  • the information can be received and the received information can be transmitted to the storage unit 120.
  • the details of the initial cell information, the acclimatization processing information, and the acclimatized pluripotent stem cell information will be described later.
  • the first communication unit 110 is provided by the provider server device 300 via the communication line. It is possible to receive the request information (delivery destination request information) regarding the (desired) conditioned pluripotent stem cell requested by the destination (customer) and transmit the received provision destination request information to the storage unit 120.
  • the provider request information includes information on the number of acclimated pluripotent stem cells and information on the degree of acclimation of the acclimated pluripotent stem cells, in addition to identification information on the corporate name, personal name, etc. of the provider. (For example, information such as requesting only the primary acclimation process, requesting both the primary acclimation process and the secondary acclimation process, requesting only a part of the primary acclimation process and the secondary acclimation process, etc.) is included as an example. Can be included as.
  • the provider request information includes information on culture conditions related to acclimatization (medium, culture vessel, temperature, pH, seeding density, number of subcultures, conditions related to subculture conditions, etc.), and acclimatized.
  • Information on the target site eg, retina, myocardium, nerve, etc.
  • information on the donation form eg, suspension culture form, cold storage form, etc.
  • usage form of the donation destination for example, Information on induction of differentiation into desired cells, screening of drugs, etc.
  • Information on the type of differentiated cell of interest in the case of performing a differentiation-inducing treatment for inducing differentiation of the acclimated pluripotent stem cell into a predetermined cell after the acclimation treatment on the acclimated pluripotent stem cell obtained by the acclimation treatment.
  • the provider requests optional information such as genetic testing, such information can also be included in the provider request information.
  • the provider provides information on safety such as impurity test, sterility / mycoplasma denial test, endotoxin test, etc. When requesting, this information can also be included in the destination request information.
  • shipping management information such as product status and transport information
  • the shipping management information is also included in the delivery destination request information. Can be included.
  • the above-mentioned communication line can include wired, wireless LAN, the Internet, etc. without limitation.
  • the first communication unit 110 receives initial cell information and acclimatization processing from the acclimatization processing device 200.
  • Various information including the information and the acclimatized pluripotent stem cell information can be transmitted to the providing destination (the server device 300 of the providing destination).
  • the recipient customer
  • the recipient is not only provided with physically acclimatized pluripotent stem cells, but also provides information related to the acclimatization process, especially information related to the acclimatized pluripotent stem cells themselves. It will be possible to receive. Therefore, it is possible to receive the donated pluripotent stem cells that are highly reliable and highly reproducible for the recipient.
  • the storage unit 120 can store the information received from the first communication unit 110.
  • the storage unit 120 can classify and store various information received from the first communication unit 110 according to the destination, the type of pluripotent stem cell, and the like.
  • the storage unit 120 can manage and store various information for each identification ID.
  • the storage unit 120 can also store various information input via the first user interface unit 150, which will be described later, and information related to various settings.
  • the determination unit 130 is a acclimated pluripotent stem cell stored in the storage unit 120 as described above. It is possible to determine whether or not there is a difference between the two after reading out the destination request information regarding the above and the acclimatized pluripotent stem cell information from the storage unit 120 and comparing the two. Specifically, for example, information on the number of cells of the acclimatized pluripotent stem cells (for example, information of "X") as the destination request information and the acclimatized pluripotent stem cells transmitted from the acclimatization processing apparatus 200.
  • information on the number of cells of the acclimatized pluripotent stem cells for example, information of "X"
  • X and Y match (or the difference between X and Y is a predetermined range. If (inside), it is judged that there is no difference between the two, and if X and Y do not match (or the difference between X and Y exceeds a predetermined range), there is a difference between the two. judge.
  • the comparison between the provider request information and the acclimatized pluripotent stem cell information by the determination unit 130 and the determination of the presence or absence of a difference between the two need not be limited to focusing on the number of cells, and other details are given. It may be replaced with information or executed in combination with other detailed information. Further, when the destination request information simply requests the submission of information regarding the cell number of the acclimatized pluripotent stem cells as the acclimatized pluripotent stem cell information (that is, the destination simply acclimatizes to the destination).
  • the determination unit 130 is stored in the storage unit 120 when only requesting that the cell number of the pluripotent stem cells be reported and the specific request regarding the cell number is not presented by the provider).
  • the determination unit 130 selects from various information stored in the storage unit 120. , The presence or absence of information corresponding to the provider request information can be determined based on whether the initial cell information or the acclimatization processing information is stored (stored).
  • the determination result of the determination unit 130 regarding whether or not there is a difference between the provision destination request information and the acclimatized pluripotent stem cell information can be transmitted to the display unit 140.
  • the administrator of the acclimatized cell management device 100 can easily confirm whether or not the acclimatized pluripotent stem cells requested by the provider can be arranged based on the determination result. That is, the administrator of the acclimatization cell management device 100 can manage whether or not the acclimatization process is appropriately executed according to the request of the provider.
  • the display unit 140 can display the determination result by the determination unit 130.
  • a general monitor screen can be used as the display unit 140, and the display unit 140 is arranged in a place where the administrator of the acclimation cell management device 100 can see.
  • the acclimatized cell management device 100 is regarded as a server device, the acclimatized cell management device 100 does not necessarily have to be provided with the display unit 140, and another terminal device owned by the administrator (for example, a smartphone). Etc.), the determination result by the determination unit 130 may be displayed on the display screen of another terminal device owned by the administrator by making it possible to connect to the acclimation cell management device 100 via the communication line. ..
  • the first user interface unit 150 can input various settings of the acclimatized cell management device 100 via the operation of the administrator.
  • the first user interface unit 150 relates to the above-mentioned difference between X and Y when the determination unit 130 determines whether or not the provision destination request information and the acclimatized pluripotent stem cell information are different from each other.
  • the "determined range" the setting of detailed information (information such as the number of cells) to be focused on when the determination unit 130 executes the determination, and the like can be input via the operation of the administrator.
  • the first user interface unit 150 can input journalizing rules (classification rules) and the like of various information stored in the storage unit 120 via the operation of the administrator.
  • the first user interface unit 150 can input information other than the information received from the acclimatization processing device 200 via the first communication unit 110 via the operation of the administrator.
  • the information other than the information received from the acclimatization processing device 200 via the first communication unit 110 and input via the first user interface unit 150 includes, for example, at least the following information.
  • Each piece of information exemplified below is input to the acclimation processing device 200 via the second user interface unit 240 described later, and then the acclimation cell management is performed from the acclimation processing device 200 via the first communication unit 110. It may be configured to be transmitted to the device 100.
  • the acclimation processing device 200 is connected to the acclimation cell management device 100 via a communication line, and can acquire various information and transmit the acquired various information to the acclimation cell management device 100 in real time. it can.
  • the acclimation processing device 200 can mainly include a acclimation processing execution unit 210, a sensor unit 220, a second communication unit 230, and a second user interface unit 240.
  • the acclimation process execution unit 210 can include all hardware that executes the primary acclimation process and the secondary acclimation process. Specifically, the acclimation process execution unit 210 includes a culture vessel used for executing the primary acclimation process, a culture container for suspension culture for executing the secondary acclimation process, a stirring member, a culture device, a medium supply device, and the like. Can be included without limitation.
  • the sensor unit 220 is provided in the acclimation processing device 200 as hardware and can acquire various information.
  • the sensor unit 220 can include various sensors such as a temperature sensor and an image sensor, for example.
  • the sensor unit 220 changes the initial cell information about the flat-cultured pluripotent stem cells (pluripotent stem cells before being subjected to the acclimatization treatment) received from the supplier, and the pluripotent stem cells from the flat culture to the suspension culture. It is possible to obtain one or more pieces of information such as acclimation processing information regarding acclimation processing and acclimated pluripotent stem cell information regarding acclimated pluripotent stem cells generated by the acclimation process as an example. ..
  • the initial cell information may include information on the cell origin (donor) and cell type (bone marrow, cord blood, skin fibroblast, fat, etc.) of pluripotent stem cells before being subjected to acclimation treatment. it can.
  • such initial cell information can be adopted as a configuration in which a barcode or an individual chip is input in association with an identification ID in a culture vessel containing pluripotent stem cells before being subjected to acclimation treatment. ..
  • the sensor unit 220 reads out the initial cell information input to the barcode, the individual chip, etc., so that the sensor unit 220 is initially set. Cell information can be acquired.
  • the acclimation processing information can include primary acclimation processing information regarding the primary acclimation processing and secondary acclimation processing information regarding the secondary acclimation processing.
  • the primary acclimation processing information includes information on the medium used for the primary acclimation treatment and information on the culture conditions (culture container volume, seeding density, temperature, pH, number of passages, passage conditions, etc.) related to the primary acclimation treatment. sell.
  • the secondary acclimation treatment information may include information on the medium used in the secondary acclimation treatment and information on the culture conditions (volume, temperature, pH, passage number, stirring speed, etc. of the culture vessel) regarding the secondary acclimation treatment.
  • the acclimatization processing information may be acquired by a sensor unit 220 such as a pH sensor, and for example, information such as the volume of the culture vessel and the number of passages is separately input by the administrator via the second user interface unit 240. You can do it.
  • a sensor unit 220 such as a pH sensor
  • the acclimated pluripotent stem cell information includes primary conditioned pluripotent stem cell information on primary conditioned pluripotent stem cells and secondary conditioned pluripotent stem cell information on secondary conditioned pluripotent stem cells.
  • the primary conditioned pluripotent stem cell information may include information on the number of cells of the primary conditioned pluripotent stem cells, cell morphological characteristics, and the like.
  • the secondary conditioned pluripotent stem cell information may include information on the number of cells of the secondary conditioned pluripotent stem cells, cell morphological characteristics, and the like.
  • the primary conditioned pluripotent stem cell information may include biochemical information relating to the primary conditioned pluripotent stem cells.
  • the secondary conditioned pluripotent stem cell information may include biochemical information relating to the secondary conditioned pluripotent stem cells.
  • the number of cells of the pluripotent stem cell that has undergone the primary acclimation treatment and the number of cells of the pluripotent stem cell that has undergone the secondary acclimation treatment can be obtained by the sensor unit 220 as an image sensor, or by another method. It can also be obtained based on.
  • the characteristics of the cell morphology can also be acquired by the sensor unit 220 as an image sensor.
  • the information regarding the characteristics of the cell morphology can include, for example, information such as the number and size of the cell mass, the shape of the cell mass, and the shape of the cell surface.
  • the sensor unit 220 can monitor the acclimation processing device 200 in real time, various information exemplarily listed as described above can be obtained in real time.
  • the sensor unit 220 can transmit all the obtained various information to the second communication unit 230.
  • the sensor unit 220 can also acquire the status of the acclimatization process executed by the acclimatization process execution unit 210 as image information or moving image information.
  • the second communication unit 230 can transmit various information received from the sensor unit 220 to the acclimation cell management device 100 (the first communication unit 110) in real time.
  • the administrator can manage in real time how the acclimation process is executed via the display unit 140 of the acclimation cell management device 100. More specifically, the administrator manages and monitors various information in real time via the display unit 140 of the acclimatization cell management device 100, so that even if some problem occurs in the acclimatization process. , You can take immediate action.
  • the second user interface unit 240 can input various settings related to the acclimatization process executed by the acclimatization process execution unit 210 via the operation of the administrator. Further, the second user interface unit 240 can acquire the above-mentioned initial cell information, acclimatization processing information, acclimatized pluripotent stem cell information and the like (for example, primary acclimatization that can be acquired based on the fluorescent staining method) that cannot be acquired by the sensor unit 220. The number of treated pluripotent stem cells and the number of cells of the secondary acclimation-treated pluripotent stem cells) can be input via the operation of the administrator.
  • the acclimatized cell management device 100 and the management system 1 including the acclimatized cell management device 100 include information on the pluripotent stem cells subjected to the acclimatization process, information on the acclimatized pluripotent stem cells, and the acclimatization process itself.
  • the habituation process can be appropriately managed and monitored. This makes it possible to provide high-quality and highly reproducible acclimatized pluripotent stem cells to the recipient (customer).
  • acclimatized pluripotent stem cells to the recipients, but also providing various information associated with them, we provide additional value to the recipients. It becomes possible to do.
  • the acclimation cell management device 100 and the acclimation processing device 200 do not necessarily have to be physically arranged in the same place (site). That is, it is also possible to manage and monitor the acclimation process of the acclimation processing device 200 by the remote acclimation cell management device 100. Therefore, for example, the acclimatization processing device 200 is lent to the provider, and the actual acclimatization process is executed by the provider, while the administrator of the acclimatization processing device 200 remotely manages, monitors (or needs) the acclimatization process. It will also be possible to provide support).

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A method for producing habituated cells, comprising: obtaining two-dimensionally cultured pluripotent stem cells from a supplier; subjecting the obtained pluripotent stem cells to a habituation treatment for enabling the transfer from two-dimensional culture to suspension culture; obtaining pluripotent stem cells that have been habituated for suspension culture by the preceding habituation treatment; and providing the habituated pluripotent stem cells to a specified customer on demand from the customer.

Description

馴化細胞作製方法、馴化細胞管理方法、馴化細胞管理装置、及びコンピュータプログラムAdaptation cell preparation method, acclimation cell management method, acclimation cell management device, and computer program
 本開示は、馴化細胞作製方法、馴化細胞管理方法、馴化細胞管理装置、及びコンピュータプログラムに関する。 The present disclosure relates to a method for producing acclimated cells, a method for managing acclimated cells, an acclimatized cell management device, and a computer program.
 多能性幹細胞としては、胚性幹細胞(ES細胞)と、誘導性多能性幹細胞(iPS細胞)とが主に知られている。これらの多能性幹細胞は、他の細胞系への分化能を保持しており、種々の条件下で目的とするステージの細胞へ分化することができる。この性質を利用して、細胞分化の研究、疾病治療への応用、医薬スクリーニング等、多くの分野で多能性幹細胞の利用が増えている。 Embryonic stem cells (ES cells) and inducible pluripotent stem cells (iPS cells) are mainly known as pluripotent stem cells. These pluripotent stem cells retain the ability to differentiate into other cell lines and can differentiate into cells of the desired stage under various conditions. Taking advantage of this property, the use of pluripotent stem cells is increasing in many fields such as cell differentiation research, disease treatment application, and drug screening.
 ところで、これらの多能性幹細胞の培養には、接着性基質材料で形成された細胞足場材が用いられるが、より小さなスペースでより大量に得るために、細胞足場材を必要としない浮遊培養が提案されている(例えば、WO2011/058558、US9018010等)。 By the way, for culturing these pluripotent stem cells, a cell scaffold material formed of an adhesive substrate material is used, but in order to obtain a larger amount in a smaller space, a suspension culture that does not require a cell scaffold material is used. It has been proposed (eg, WO2011 / 058558, US901801, etc.).
 しかしながら、多能性幹細胞は、本来は接着性の細胞であるため、浮遊培養に即時に適用しにくい傾向がある。このため、一定量の多能性幹細胞が必要になってから馴化処理を始めては時間がかかる上に、手間がかかる。
 本開示は、手間を省きながら、浮遊培養に馴化された多能性幹細胞を得る馴化細胞作製方法を提供することを目的とする。また、馴化処理に供される多能性幹細胞の情報、馴化された多能性幹細胞の情報、及び馴化処理そのものの情報等の様々な情報を取得することで馴化処理を適切に管理すること、さらに、顧客に対して馴化された多能性幹細胞を提供する際に追加的な付加価値を提供することが可能な、馴化細胞作製方法、馴化細胞管理方法、馴化細胞管理装置、及びコンピュータプログラムを提供することを別の目的とする。
However, since pluripotent stem cells are originally adhesive cells, they tend to be difficult to apply immediately to suspension culture. For this reason, it takes time and labor to start the acclimatization process after a certain amount of pluripotent stem cells are required.
An object of the present disclosure is to provide a method for producing acclimated cells to obtain pluripotent stem cells acclimated to suspension culture while saving time and effort. In addition, it is necessary to appropriately manage the acclimation process by acquiring various information such as information on the pluripotent stem cells to be subjected to the acclimation process, information on the acclimated pluripotent stem cells, and information on the acclimation process itself. In addition, acclimation cell production methods, acclimation cell management methods, acclimation cell management devices, and computer programs that can provide additional value in providing acclimated pluripotent stem cells to customers. Another purpose is to provide.
 本開示は、以下の態様を提供する。
 本開示の一態様に係る馴化細胞作製方法は、平面培養された多能性幹細胞を供給元から受領すること、受領した多能性幹細胞に対し、平面培養から浮遊培養への移行を可能にするための馴化処理を行うこと、前記馴化処理によって、浮遊培養に馴化した多能性幹細胞を得ること、及び、得られた馴化済み多能性幹細胞を、提供先からの要求に応じて、指定された提供先に提供すること、を含む。
The present disclosure provides the following aspects.
The method for producing acclimated cells according to one aspect of the present disclosure enables the reception of flat-cultured pluripotent stem cells from a supplier and the transition of the received pluripotent stem cells from flat culture to suspension culture. To obtain pluripotent stem cells acclimated to suspension culture by the acclimation treatment, and to specify the obtained acclimated pluripotent stem cells according to the request from the provider. Including providing to the destination.
 また、一態様に係る前記馴化細胞作製方法において、前記馴化処理が、受領した多能性幹細胞を、一次馴化用培地を充填した一次馴化用培養容器にて一次馴化培養を行い、一次馴化済み多能性幹細胞を得る一次馴化処理、及び、前記一次馴化済み多能性幹細胞を、二次馴化用培地を充填した浮遊培養用容器にて浮遊培養を行い、浮遊培養に馴化した二次馴化済み多能性幹細胞を得る二次馴化処理、を含む。 Further, in the method for producing acclimated cells according to one aspect, the pluripotent stem cells received by the acclimation treatment are subjected to primary acclimation culture in a primary acclimation culture vessel filled with a primary acclimation medium, and the primary acclimation has been performed. The primary acclimation treatment to obtain pluripotent stem cells and the suspension culture of the primary acclimated pluripotent stem cells in a suspension culture container filled with a secondary acclimation medium were performed, and the secondary acclimated polyplasia was acclimated to the suspension culture. Includes a secondary acclimation process to obtain capable stem cells.
 また、一態様に係る前記馴化細胞作製方法は、前記馴化処理に供される前の前記多能性幹細胞に関する初期細胞情報、前記一次馴化処理に関する一次馴化処理情報、前記二次馴化処理に関する二次馴化処理情報、前記一次馴化済み多能性幹細胞に関する一次馴化済み多能性幹細胞情報、及び、前記二次馴化済み多能性幹細胞に関する二次馴化済み多能性幹細胞情報からなる群より選択される少なくとも一つの情報を入手すること、をさらに含む。 In addition, the method for producing acclimated cells according to one embodiment includes initial cell information regarding the pluripotent stem cells before being subjected to the acclimation treatment, primary acclimation processing information regarding the primary acclimation treatment, and secondary acclimation treatment. Selected from the group consisting of acclimation processing information, primary acclimated pluripotent stem cell information on the primary acclimated pluripotent stem cell, and secondary acclimated pluripotent stem cell information on the secondary acclimated pluripotent stem cell. Further including obtaining at least one piece of information.
 また、一態様に係る前記馴化細胞作製方法において、前記初期細胞情報は、前記馴化処理に供される前の前記多能性幹細胞の細胞種に関する情報を少なくとも含む。 Further, in the method for producing an acclimated cell according to one aspect, the initial cell information includes at least information on the cell type of the pluripotent stem cell before being subjected to the acclimation treatment.
 また、一態様に係る前記馴化細胞作製方法において、前記一次馴化処理情報は、前記一次馴化用培地に関する情報、及び前記一次馴化処理に関する培養条件に関する情報を少なくとも含む。 Further, in the method for producing acclimated cells according to one aspect, the primary acclimation treatment information includes at least information on the primary acclimation medium and information on culture conditions related to the primary acclimation treatment.
 また、一態様に係る前記馴化細胞作製方法において、前記二次馴化処理情報は、前記二次馴化用培地に関する情報、及び前記二次馴化処理に関する浮遊培養条件に関する情報を少なくとも含む。 Further, in the method for producing acclimated cells according to one aspect, the secondary acclimation treatment information includes at least information on the secondary acclimation medium and information on suspension culture conditions related to the secondary acclimation treatment.
 また、一態様に係る前記馴化細胞作製方法において、前記一次馴化済み多能性幹細胞情報は、前記一次馴化済み多能性幹細胞の細胞数、及び細胞形態の特徴に関する情報を少なくとも含み、前記二次馴化済み多能性幹細胞情報は、前記二次馴化済み多能性幹細胞の細胞数、及び細胞形態の特徴に関する情報を少なくとも含む。 Further, in the method for producing acclimated cells according to one aspect, the primary conditioned pluripotent stem cell information includes at least information on the number of cells of the primary conditioned pluripotent stem cells and the characteristics of cell morphology, and the secondary The conditioned pluripotent stem cell information includes at least information on the cell number of the secondary conditioned pluripotent stem cells and the characteristics of cell morphology.
 また、一態様に係る前記馴化細胞作製方法は、前記初期細胞情報、前記一次馴化処理情報、前記二次馴化処理情報、前記一次馴化済み多能性幹細胞情報、及び前記二次馴化済み多能性幹細胞情報からなる群より選択される少なくとも一つの入手された情報を前記提供先に提供すること、をさらに含む。 In addition, the method for producing acclimated cells according to one embodiment includes the initial cell information, the primary acclimation processing information, the secondary acclimation processing information, the primary acclimated pluripotent stem cell information, and the secondary acclimated pluripotency. Further comprising providing the provider with at least one obtained information selected from the group consisting of stem cell information.
 また、一態様に係る前記馴化細胞作製方法において、前記馴化済み多能性幹細胞は、浮遊培養形態で前記提供先に提供される。 Further, in the method for producing acclimated cells according to one aspect, the acclimated pluripotent stem cells are provided to the donor in a suspended culture form.
 本開示の一態様に係る馴化細胞管理方法は、コンピュータにより読み取り可能な命令を実行する少なくとも1つのプロセッサにより実行される馴化細胞管理方法であって、前記少なくとも1つのプロセッサが、前記命令を実行することにより、平面培養された多能性幹細胞に関する初期細胞情報を取得して記憶し、前記多能性幹細胞に対し、平面培養から浮遊培養への移行を可能にするための馴化処理に関する馴化処理情報を取得して記憶し、前記馴化処理によって生成される馴化済み多能性幹細胞に関する馴化済み多能性幹細胞情報を取得して記憶する。 The acclimation cell management method according to one aspect of the present disclosure is a acclimation cell management method executed by at least one processor that executes a computer-readable instruction, and the at least one processor executes the instruction. Thereby, the initial cell information regarding the planar cultured pluripotent stem cells is acquired and stored, and the acclimatization processing information regarding the acclimatization process for enabling the transition from the planar culture to the suspension culture for the pluripotent stem cells is performed. Is acquired and stored, and the acclimatized pluripotent stem cell information regarding the acclimatized pluripotent stem cells generated by the acclimatization process is acquired and stored.
 また、一態様に係る前記馴化細胞管理方法において、前記少なくとも1つのプロセッサは、前記命令を実行することにより、さらに、前記馴化済み多能性幹細胞が提供される提供先の、前記馴化済み多能性幹細胞に対する要求に関する提供先要求情報を予め取得して記憶し、前記提供先要求情報と前記馴化済み多能性幹細胞情報とを比較して、両者間に相違があるか否かを判定する。 Further, in the acclimated cell management method according to one embodiment, the at least one processor executes the instruction to further provide the acclimated pluripotent stem cell to the destination to which the acclimated pluripotent stem cell is provided. The donor request information regarding the request for the sex stem cell is acquired and stored in advance, and the donor request information is compared with the acclimatized pluripotent stem cell information to determine whether or not there is a difference between the two.
 また、一態様に係る前記馴化細胞管理方法において、前記少なくとも1つのプロセッサは、前記命令を実行することにより、さらに、前記初期細胞情報、前記馴化処理情報、及び前記馴化済み多能性幹細胞情報からなる群より選択される少なくとも一つの情報を、通信回線を介して、前記馴化済み多能性幹細胞が提供される提供先の提供先サーバ装置に送信する。 Further, in the acclimation cell management method according to one aspect, the at least one processor further obtains the initial cell information, the acclimation processing information, and the acclimated pluripotent stem cell information by executing the instruction. At least one piece of information selected from the group is transmitted to the destination server device to which the acclimatized pluripotent stem cells are provided via a communication line.
 また、一態様に係る前記馴化細胞管理方法において、前記初期細胞情報、前記馴化処理情報、及び前記馴化済み多能性幹細胞情報は、前記馴化処理を実行する馴化処理装置から通信回線を介して取得される。 Further, in the acclimation cell management method according to one aspect, the initial cell information, the acclimation processing information, and the acclimated pluripotent stem cell information are acquired from the acclimation processing device that executes the acclimation processing via a communication line. Will be done.
 また、一態様に係る前記馴化細胞管理方法において、前記提供先要求情報は、前記提供先の提供先サーバ装置から通信回線を介して取得される。 Further, in the acclimation cell management method according to one aspect, the provision destination request information is acquired from the provision destination server device of the provision destination via a communication line.
 また、一態様に係る前記馴化細胞管理方法において、前記馴化処理は、前記多能性幹細胞を、一次馴化用培地を充填した一次馴化用培養容器にて一次馴化培養を行い、一次馴化済み多能性幹細胞を得る一次馴化処理、及び、前記一次馴化済み多能性幹細胞を、二次馴化用培地を充填した浮遊培養用容器にて浮遊培養を行い、浮遊培養に馴化した二次馴化済み多能性幹細胞を得る二次馴化処理、を含み、前記馴化処理情報は、前記一次馴化処理に関する一次馴化処理情報、及び、前記二次馴化処理に関する二次馴化処理情報を含み、前記馴化済み多能性幹細胞情報は、前記一次馴化済み多能性幹細胞に関する一次馴化済み多能性幹細胞情報、及び、前記二次馴化済み多能性幹細胞に関する二次馴化済み多能性幹細胞情報を含む。 Further, in the acclimation cell management method according to one aspect, in the acclimation treatment, the pluripotent stem cells are subjected to primary acclimation culture in a primary acclimation culture vessel filled with a primary acclimation medium, and the primary acclimated pluripotency is performed. The primary acclimation treatment for obtaining sex stem cells and the suspension culture of the primary acclimated pluripotent stem cells in a suspension culture container filled with a secondary acclimation medium are performed, and the secondary acclimated pluripotency acclimated to the suspension culture is performed. The acclimation processing information includes the primary acclimation processing information regarding the primary acclimation process and the secondary acclimation processing information regarding the secondary acclimation process, and includes the secondary acclimation process for obtaining sex stem cells. The stem cell information includes the primary acclimated pluripotent stem cell information regarding the primary conditioned pluripotent stem cell and the secondary conditioned pluripotent stem cell information regarding the secondary conditioned pluripotent stem cell.
 また、一態様に係る前記馴化細胞管理方法において、前記初期細胞情報は、前記多能性幹細胞の細胞種に関する情報を少なくとも含む。 Further, in the acclimated cell management method according to one aspect, the initial cell information includes at least information on the cell type of the pluripotent stem cell.
 また、一態様に係る前記馴化細胞管理方法において、前記一次馴化処理情報は、前記一次馴化用培地に関する情報、及び前記一次馴化処理に関する培養条件に関する情報を少なくとも含む。 Further, in the acclimation cell management method according to one aspect, the primary acclimation treatment information includes at least information on the primary acclimation medium and information on culture conditions related to the primary acclimation treatment.
 また、一態様に係る前記馴化細胞管理方法において、前記二次馴化処理情報は、前記二次馴化用培地に関する情報、及び前記二次馴化処理に関する浮遊培養情報に関する情報を少なくとも含む。 Further, in the acclimation cell management method according to one aspect, the secondary acclimation processing information includes at least information on the secondary acclimation medium and information on suspension culture information on the secondary acclimation treatment.
 また、一態様に係る前記馴化細胞管理方法において、前記一次馴化済み多能性幹細胞情報は、前記一次馴化済み多能性幹細胞の細胞数、及び細胞形態の特徴に関する情報を少なくとも含み、前記二次馴化済み多能性幹細胞情報は、前記二次馴化済み多能性幹細胞の細胞数、及び細胞形態の特徴に関する情報を少なくとも含む。 Further, in the conditioned cell management method according to one aspect, the primary conditioned pluripotent stem cell information includes at least information on the number of cells of the primary conditioned pluripotent stem cell and the characteristics of cell morphology, and the secondary The conditioned pluripotent stem cell information includes at least information on the cell number of the secondary conditioned pluripotent stem cells and the characteristics of cell morphology.
 本開示の一態様に係る馴化細胞管理装置は、1又は複数のプロセッサを具備し、該プロセッサが、平面培養された多能性幹細胞に関する初期細胞情報を取得して記憶し、前記多能性幹細胞に対し、平面培養から浮遊培養への移行を可能にするための馴化処理を行う馴化処理に関する馴化処理情報を取得して記憶し、前記馴化処理によって生成される馴化済み多能性幹細胞に関する馴化済み多能性幹細胞情報を取得して記憶する、ように前記少なくとも1つのプロセッサを機能させる。 The acclimated cell management apparatus according to one aspect of the present disclosure includes one or a plurality of processors, and the processors acquire and store initial cell information regarding plane-cultured pluripotent stem cells, and the pluripotent stem cells. On the other hand, the acclimation process information related to the acclimation process for performing the acclimation process to enable the transition from the planar culture to the suspension culture is acquired and stored, and the acclimated pluripotent stem cells generated by the acclimatization process have been acclimatized. The at least one processor is made to function so as to acquire and store pluripotent stem cell information.
 また、一態様に係る前記馴化細胞管理装置は、前記馴化済み多能性幹細胞が提供される提供先の、前記馴化済み多能性幹細胞に対する要求に関する提供先要求情報を予め取得して記憶し、前記提供先要求情報と前記馴化済み多能性幹細胞情報とを比較して、両者間に相違があるか否かを判定する、ように前記少なくとも1つのプロセッサをさらに機能させる。 In addition, the acclimated cell management device according to one aspect acquires and stores in advance destination request information regarding a request for the acclimated pluripotent stem cell of the destination to which the acclimated pluripotent stem cell is provided. The at least one processor is further functionalized to compare the destination request information with the acclimatized pluripotent stem cell information to determine if there is a difference between the two.
 また、一態様に係る前記馴化細胞管理装置は、前記初期細胞情報、前記馴化処理情報、及び前記馴化済み多能性幹細胞情報からなる群より選択される少なくとも一つの情報を、通信回線を介して、前記馴化済み多能性幹細胞が提供される提供先の提供先サーバ装置に送信する、ように前記少なくとも1つのプロセッサをさらに機能させる。 In addition, the acclimatized cell management device according to one aspect transmits at least one information selected from the group consisting of the initial cell information, the acclimatization processing information, and the acclimatized pluripotent stem cell information via a communication line. The at least one processor is further functionalized to transmit the conditioned pluripotent stem cells to a destination server device to which the cells are provided.
 また、一態様に係る前記馴化細胞管理装置において、前記初期細胞情報、前記馴化処理情報、及び前記馴化済み多能性幹細胞情報は、前記馴化処理を実行する馴化処理装置から通信回線を介して取得される。 Further, in the acclimation cell management device according to one aspect, the initial cell information, the acclimation processing information, and the acclimated pluripotent stem cell information are acquired from the acclimation processing device that executes the acclimation processing via a communication line. Will be done.
 また、一態様に係る前記馴化細胞管理装置において、前記提供先要求情報は、前記提供先の提供先サーバ装置から通信回線を介して取得される。 Further, in the acclimatized cell management device according to one aspect, the provision destination request information is acquired from the provision destination server device of the provision destination via a communication line.
 本開示の一態様に係るコンピュータプログラムは、少なくとも1つのプロセッサにより実行されることにより、平面培養された多能性幹細胞に関する初期細胞情報を取得して記憶し、前記多能性幹細胞に対し、平面培養から浮遊培養への移行を可能にするための馴化処理を行う馴化処理に関する馴化処理情報を取得して記憶し、前記馴化処理によって生成される馴化済み多能性幹細胞に関する馴化済み多能性幹細胞情報を取得して記憶する、ように前記少なくとも1つのプロセッサを機能させる。 The computer program according to one aspect of the present disclosure acquires and stores initial cell information about pluripotent stem cells cultured in a plane by being executed by at least one processor, and planes the pluripotent stem cells. Performs acclimation processing to enable the transition from culture to suspension culture Acquires and stores acclimation processing information related to the acclimation process, and acclimatized pluripotent stem cells related to the acclimated pluripotent stem cells generated by the acclimation process. The at least one processor is made to function so as to acquire and store information.
 また、一態様に係る前記コンピュータプログラムは、前記馴化済み多能性幹細胞が提供される提供先の、前記馴化済み多能性幹細胞に対する要求に関する提供先要求情報を予め取得して記憶し、前記提供先要求情報と前記馴化済み多能性幹細胞情報とを比較して、両者間に相違があるか否かを判定する、ように前記少なくとも1つのプロセッサをさらに機能させる。 In addition, the computer program according to one aspect acquires, stores, and stores in advance the destination request information regarding the request for the conditioned pluripotent stem cell of the destination to which the conditioned pluripotent stem cell is provided, and provides the provided information. The at least one processor is further functionalized to compare the prior demand information with the acclimated pluripotent stem cell information to determine if there is a difference between the two.
 また、一態様に係る前記コンピュータプログラムは、前記初期細胞情報、前記馴化処理情報、及び前記馴化済み多能性幹細胞情報からなる群より選択される少なくとも一つの情報を、通信回線を介して、前記馴化済み多能性幹細胞が提供される提供先の提供先サーバ装置に送信する、ように前記少なくとも1つのプロセッサをさらに機能させる。 Further, the computer program according to one aspect obtains at least one piece of information selected from the group consisting of the initial cell information, the acclimatization processing information, and the acclimatized pluripotent stem cell information via a communication line. The at least one processor is further functionalized such that the conditioned pluripotent stem cells transmit to the destination server device of the destination to which they are provided.
 また、一態様に係る前記コンピュータプログラムにおいて、前記初期細胞情報、前記馴化処理情報、及び前記馴化済み多能性幹細胞情報は、前記馴化処理を実行する馴化処理装置から通信回線を介して取得される。 Further, in the computer program according to one aspect, the initial cell information, the acclimation processing information, and the acclimated pluripotent stem cell information are acquired from the acclimation processing device that executes the acclimation processing via a communication line. ..
 また、一態様に係る前記コンピュータプログラムにおいて、前記提供先要求情報は、前記提供先の提供先サーバ装置から通信回線を介して取得される。 Further, in the computer program according to one aspect, the provision destination request information is acquired from the provision destination server device of the provision destination via a communication line.
 本開示によれば、手間を省きながら、浮遊培養に馴化された多能性幹細胞を得る馴化細胞作製方法を提供することができる。また、本開示によれば、馴化処理に供される多能性幹細胞の情報、馴化された多能性幹細胞の情報、及び馴化処理そのものの情報等の様々な情報を取得することで馴化処理を適切に管理すること、さらに、顧客に対して馴化された多能性幹細胞を提供する際に追加的な付加価値を提供することができる馴化細胞管理方法、馴化細胞管理装置、及びコンピュータプログラムを提供することができる。 According to the present disclosure, it is possible to provide a method for producing acclimated cells to obtain pluripotent stem cells acclimated to suspension culture while saving time and effort. Further, according to the present disclosure, the acclimatization process is performed by acquiring various information such as information on the pluripotent stem cells to be subjected to the acclimatization process, information on the acclimatized pluripotent stem cells, and information on the acclimatization process itself. Providing acclimation cell management methods, acclimation cell management devices, and computer programs that can be properly managed and also provide additional value in providing acclimated pluripotent stem cells to customers. can do.
一実施形態に係る馴化細胞管理装置を含む管理システムの構成の一例を示すブロック図である。It is a block diagram which shows an example of the structure of the management system including the acclimatization cell management apparatus which concerns on one Embodiment. 図1に示した馴化細胞管理装置の機能の一例を模式的に示すブロック図である。It is a block diagram which shows typically an example of the function of the acclimation cell management apparatus shown in FIG. 図1に示した馴化処理装置の機能の一例を模式的に示すブロック図である。It is a block diagram which shows typically an example of the function of the acclimatization processing apparatus shown in FIG.
 本明細書において、「~」を用いて示された数値範囲は、「~」の前後に記載される数値をそれぞれ最小値及び最大値として含む範囲を示す。本明細書において、組成物中の各成分の含有量は、組成物中に各成分に該当する物質が複数存在する場合、特に断らない限り、組成物中に存在する当該複数の物質の合計量を意味する。「工程」との語は、独立した工程だけではなく、他の工程と明確に区別できない場合であってもその工程の所期の作用が達成されれば、本用語に含まれる。 In the present specification, the numerical range indicated by using "-" indicates a range including the numerical values before and after "-" as the minimum value and the maximum value, respectively. In the present specification, the content of each component in the composition is the total amount of the plurality of substances present in the composition unless otherwise specified, when a plurality of substances corresponding to each component are present in the composition. Means. The term "process" is included in the term not only in an independent process but also in the case where the desired action of the process is achieved even if it cannot be clearly distinguished from other processes.
 本開示の一態様に係る馴化細胞作製方法は、平面培養された多能性幹細胞を供給元から受領すること(以下、受領工程という)、受領した多能性幹細胞に対し、平面培養から浮遊培養への移行を可能にするための馴化処理を行うこと(以下、馴化工程という)、前記馴化処理によって、浮遊培養に馴化した多能性幹細胞を得ること、及び、得られた馴化済み多能性幹細胞を、提供先からの要求に応じて、指定された提供先に提供すること(以下、提供工程という)を含む。
 これら本開示の馴化細胞作製方法によれば、手間を省きながら、浮遊培養に馴化された多能性幹細胞を得ることができる。
The method for producing acclimated cells according to one aspect of the present disclosure is to receive the pluripotent stem cells cultured in a plane from a supplier (hereinafter referred to as a receiving step), and to suspend the received pluripotent stem cells from a plane culture. Performing an acclimatization treatment to enable the transition to (hereinafter referred to as an acclimatization step), obtaining pluripotent stem cells acclimatized to suspension culture by the acclimatization treatment, and the obtained pluripotent pluripotency It includes providing stem cells to a designated donation destination (hereinafter referred to as a donation step) in response to a request from the donation destination.
According to these methods for producing acclimated cells of the present disclosure, pluripotent stem cells acclimated to suspension culture can be obtained while saving time and effort.
 これを更に説明すれば、本馴化細胞作製方法によれば、平面培養された多能性幹細胞は、供給元から得たものである。この得られた多能性幹細胞に対して特定の馴化処理を行って得られた馴化済み多能性幹細胞は、提供先からの要求に応じて、指定された提供先に提供される。したがって、提供先は、馴化処理を行う必要がなく、浮遊培養に馴化された多能性幹細胞を要求したときに入手することができる。ここで、供給元と提供先とは同一であっても異なっていてもよい。本明細書において「提供先」との記載は、「供給元」と読み替えてもよく、場合によっては、「提供先」及び「供給元」の双方に読み替えてもよい。馴化処理は、供給元及び提供先と異なる場所、機関等で実施する。以下、本明細書では、馴化処理を実施する場所、機関等を、便宜上、「馴化実施機関」と称する場合がある。本明細書では、培養培地を単に「培地」と称する場合がある。
 以下、本馴化細胞作製方法について説明する。
To further explain this, according to this method for producing acclimated cells, the pluripotent stem cells cultured in a plane are obtained from a supplier. The acclimated pluripotent stem cells obtained by subjecting the obtained pluripotent stem cells to a specific acclimation treatment are provided to a designated donor in response to a request from the donor. Therefore, the donor can obtain the pluripotent stem cells that have been acclimatized to the suspension culture when they are requested without the need for acclimatization treatment. Here, the supply source and the supply destination may be the same or different. In the present specification, the description of "provider" may be read as "supply source", and in some cases, may be read as both "provider" and "supply source". The acclimation process is carried out at a place, institution, etc. different from the supply source and the supply destination. Hereinafter, in the present specification, a place, an institution, etc. that performs habituation processing may be referred to as a "habituation executing agency" for convenience. In the present specification, the culture medium may be simply referred to as "medium".
Hereinafter, the method for producing the acclimated cells will be described.
 1.馴化細胞作製方法
 受領工程では、平面培養された多能性幹細胞を供給元から受領する。本明細書において「多能性幹細胞」としては、複数の細胞への分化能と自己複製能を有する未分化細胞であれば制限はなく、胚性幹細胞(ES細胞)、誘導性多能性幹細胞(iPS細胞)、間葉系幹細胞(MSC)、Muse細胞等を挙げることができ、中でも、内胚葉、中胚葉及び外胚葉の三胚葉系列すべてに分化できるES細胞、iPS細胞であってもよい。これらの多能性幹細胞の由来については特に制限はなく、例えば、ヒト、サル、マウス、ラット、ブタ、イヌ等を挙げることができる。
1. 1. In the process of receiving the acclimated cell preparation method , the flat-cultured pluripotent stem cells are received from the supplier. In the present specification, the “pluripotent stem cell” is not limited as long as it is an undifferentiated cell having the ability to differentiate into a plurality of cells and self-renewal ability, and is an embryonic stem cell (ES cell) or an inducible pluripotent stem cell. (IPS cells), mesenchymal stem cells (MSCs), Muse cells and the like can be mentioned, and among them, ES cells and iPS cells capable of differentiating into all three embryonic lineages of endometrial, mesenchymal and ectodermal can be used. .. The origin of these pluripotent stem cells is not particularly limited, and examples thereof include humans, monkeys, mice, rats, pigs, and dogs.
 受領工程で得られる多能性幹細胞は、平面培養されたものである。ここで平面培養とは、場合によって二次元培養ともいい、平面を有する培養容器の培養面上に細胞を接着させて培養する培養方法を指す。培養容器の培養面となる平面は、細胞親和性のポリマー、フィーダー細胞の細胞層、ビトロネクチン、フィブロネクチン、コラーゲン、マトリゲル(登録商標、以下省略)等の細胞外マトリックス、又はこれらの部分ペプチドを、細胞足場材として備えたものであってもよい。平面培養に用いられる培地は、対象となる多能性幹細胞の種類に応じて適宜選択可能であり、例えば、10%(v/v)FBS含有のDMEM又はDMEM-F12を挙げることができる。平面培養の培養条件としては、対象となる多能性幹細胞に通常適用される条件であればよく、例えば37℃の温度条件下、10%CO環境下とすることができる。培養条件は、細胞の分化ステージが変化しない範囲で、細胞の状態に応じて適宜変更することができる。 The pluripotent stem cells obtained in the receiving step are plane-cultured. Here, the planar culture is also referred to as two-dimensional culture in some cases, and refers to a culture method in which cells are adhered and cultured on the culture surface of a culture vessel having a flat surface. The plane that becomes the culture surface of the culture vessel is a cell of a cell-affinitive polymer, a cell layer of a feeder cell, an extracellular matrix such as vitronectin, fibronectin, collagen, Matrigel (registered trademark, hereinafter omitted), or a partial peptide thereof. It may be provided as a scaffolding material. The medium used for the planar culture can be appropriately selected depending on the type of pluripotent stem cells to be targeted, and examples thereof include DMEM or DMEM-F12 containing 10% (v / v) FBS. The culture conditions for the planar culture may be any conditions normally applied to the target pluripotent stem cells, and can be, for example, a temperature condition of 37 ° C. and a 10% CO 2 environment. The culture conditions can be appropriately changed according to the state of the cells as long as the differentiation stage of the cells does not change.
 受領方法としては、一般に細胞の授受が可能な提供形態であればよく、液体培養形態、凍結保存形態等が挙げられる。多能性幹細胞は、供給元から馴化実施機関に移送されてもよい。移送は、恒温移送、冷蔵移送、冷凍移送等、供給元からの提供形態に応じた移送形式を適宜選択すればよい。 As the receiving method, generally, any form can be provided as long as the cells can be transferred, and examples thereof include a liquid culture form and a cryopreservation form. Pluripotent stem cells may be transferred from the source to the acclimatization agency. For the transfer, a transfer form such as a constant temperature transfer, a refrigerated transfer, a frozen transfer, or the like may be appropriately selected according to the form of provision from the supplier.
 馴化工程では、受領した多能性幹細胞に対し、平面培養から浮遊培養への移行を可能にするための馴化処理が行われる。本明細書において「浮遊培養」とは、細胞を平面に接着させるのではなく、培地中に浮遊させて培養する培養方法を指す。換言すれば、本明細書において、馴化処理とは、二次元環境となる平面に付着して成育する静的な成育環境下に適応している多能性幹細胞を、三次元環境となる培養液系内に細胞が分散して成育する浮遊環境へ細胞を少しずつ「馴らす」処理である。馴化工程では、細胞は、単一細胞として培地中に分散していてもよく、複数の細胞が集積してスフェロイドを形成してもよく、細胞が接着可能なマイクロビーズ等のマイクロキャリアに付着した状態であってもよく、馴化工程中で、これら異なる状態の時期を有してもよい。馴化処理用に複数の培地を用いてよく、培養温度、pH、培地の攪拌等の培養条件を変更してもよい。馴化工程における培養では、細胞の状態に応じて適切な細胞数を維持するように所定のタイミングで継代を繰り返すことにより、細胞を維持し、増やすことができる。培養は、例えば37℃の温度条件下、10%CO環境下で行うことができる。
 馴化工程を経ることによって、浮遊培養に馴化した多能性幹細胞を得ることができる。
In the acclimation step, the received pluripotent stem cells are acclimated to enable the transition from planar culture to suspension culture. As used herein, the term "suspended culture" refers to a culture method in which cells are suspended and cultured in a medium rather than being adhered to a flat surface. In other words, in the present specification, the acclimatization treatment refers to a culture medium in which pluripotent stem cells adapted to a static growth environment that grows by adhering to a plane that becomes a two-dimensional environment are used as a three-dimensional environment. It is a process of gradually "acclimating" cells to a floating environment in which cells are dispersed and grow in the system. In the acclimation step, the cells may be dispersed in the medium as a single cell, a plurality of cells may accumulate to form a spheroid, and the cells adhere to microcarriers such as microbeads to which they can adhere. It may be in a state or may have periods of these different states during the acclimatization process. A plurality of media may be used for the acclimation treatment, and the culture conditions such as the culture temperature, pH, and stirring of the medium may be changed. In the culture in the acclimation step, cells can be maintained and increased by repeating the passage at a predetermined timing so as to maintain an appropriate number of cells according to the state of the cells. The culture can be carried out under a temperature condition of, for example, 37 ° C. and in a 10% CO 2 environment.
By going through the acclimation step, pluripotent stem cells acclimated to suspension culture can be obtained.
 馴化処理は、更に、受領した多能性幹細胞を、一次馴化用培地を充填した一次馴化用培養容器にて一次馴化培養を行い、一次馴化済み多能性幹細胞を得ること(以下、一次馴化処理)、一次馴化済み多能性幹細胞を、二次馴化用培地を充填した浮遊培養用容器にて浮遊培養を行うこと(以下、二次馴化処理)、二次馴化用培地によって、浮遊培養に馴化した二次馴化済み多能性幹細胞を得ることを含むことができる。
 馴化処理を、培地及び培養容器が異なる二段階の馴化処理とすることによって、より確実に浮遊培養に馴化した多能性幹細胞を効率良く得ることができる。
In the acclimatization treatment, the received pluripotent stem cells are further subjected to primary acclimatization culture in a primary acclimatization culture vessel filled with a primary acclimatization medium to obtain primary acclimatized pluripotent stem cells (hereinafter, primary acclimatization treatment). ), The primary acclimated pluripotent stem cells are subjected to suspension culture in a suspension culture container filled with a secondary acclimation medium (hereinafter referred to as secondary acclimation treatment), and the secondary acclimation medium is used for suspension culture. It can include obtaining secondary conditioned pluripotent stem cells.
By performing the acclimation treatment in two stages in which the medium and the culture vessel are different, pluripotent stem cells acclimated to the suspension culture can be more reliably obtained.
 一次馴化処理は、一次馴化用培地及び一次馴化用培養容器を用いる。一次馴化処理で使用される一次馴化用培地及び一次馴化用培養容器は、多能性幹細胞受領前の平面培養で用いられた培地又は培養容器と少なくとも一方が異なるものであればよい。これにより、受領前の平面培養とは異なる培養環境下に、多能性幹細胞を供することができる。一次馴化処理は、細胞受領前の平面培養又は二次馴化処理の培養条件と、培地及び培養容器の少なくとも一方が異なるものであれば、平面培養段階と、二次馴化処理とは異なる条件による浮遊培養段階との少なくとも一方の段階を含むことができ、平面培養段階と浮遊培養段階との双方を含むことができる。一次馴化処理を、平面培養段階と浮遊培養段階の二段階で構成される多段階一次馴化処理とすることにより、馴化によるストレスを一層少なく穏やかに細胞の馴化を行うことができ、更に効率良く浮遊培養に馴化した多能性幹細胞を得ることができる。 For the primary acclimation treatment, a primary acclimation medium and a primary acclimation culture container are used. The primary acclimation medium and the primary acclimation culture vessel used in the primary acclimation treatment may be at least one different from the medium or culture vessel used in the plane culture before receiving the pluripotent stem cells. As a result, pluripotent stem cells can be provided in a culture environment different from that of the planar culture before receipt. In the primary acclimation treatment, if at least one of the medium and the culture vessel is different from the culture conditions of the plane culture or the secondary acclimation treatment before receiving the cells, the plane culture stage and the floating under the conditions different from the secondary acclimation treatment. At least one stage with the culture stage can be included, and both the plane culture stage and the suspension culture stage can be included. By making the primary acclimation process a multi-step primary acclimation process consisting of two stages, a plane culture stage and a suspension culture stage, it is possible to perform cell acclimation gently with less stress due to acclimation, and the cells float more efficiently. Pluripotent stem cells acclimated to culture can be obtained.
 一次馴化処理における平面培養段階の培養条件は、受領した多能性幹細胞に対して行われていた平面培養とは同一の条件であってもよく、異なる条件であってもよい。ここでいう培養条件には、使用する培地、培養容器、温度、pH等が挙げられる。一次馴化処理における平面培養段階では、マトリゲル等の細胞外マトリックス、マウス胚性線維芽細胞(MEF)等の細胞足場材を、培養面上に用いてもよく、特に異種由来成分を有しないマトリゲルを用いることができる。 The culture conditions at the plane culture stage in the primary acclimatization treatment may be the same as or different from the plane culture performed on the received pluripotent stem cells. Examples of the culture conditions referred to here include the medium to be used, the culture vessel, temperature, pH and the like. In the planar culture step in the primary acclimation treatment, extracellular matrix such as Matrigel and cell scaffold material such as mouse embryonic fibroblast (MEF) may be used on the culture surface, and Matrigel having no heterologous component may be used. Can be used.
 一次馴化処理における平面培養段階は、受領した多能性幹細胞に対して行われていた平面培養と異なる培地を用いることができる。一次馴化処理における平面培養段階では、例えば、ヒト塩基性線維芽細胞増殖因子(bFGF)、TGFβ1、GABA、ウシ血清アルブミン(BSA)、コレステロール等を含有するDMEM-F12等の培地を平面培養段階用培地として用いることができる。培養容器としては、例えば、細胞足場材としてマトリゲルをコーティングしたディッシュを用いることができる。平面培養段階は、所定の細胞数、例えば、1×10~3×10個程度に到達した段階で終了することができる。平面培養段階に続けて浮遊培養段階を行う場合には、平面培養中の細胞を、トリプシン等の酵素処理で回収し、浮遊培養段階に移行することができる。 For the planar culture step in the primary acclimation treatment, a medium different from the planar culture performed on the received pluripotent stem cells can be used. In the plane culture stage in the primary acclimation treatment, for example, a medium containing DMEM-F12 containing human basic fibroblast growth factor (bFGF), TGFβ1, GABA, bovine serum albumin (BSA), cholesterol, etc. is used for the plane culture stage. It can be used as a medium. As the culture vessel, for example, a dish coated with Matrigel as a cell scaffolding material can be used. The plane culture step can be completed when the number of cells reaches a predetermined number, for example, about 1 × 10 6 to 3 × 10 6. When the suspension culture stage is performed following the plane culture stage, the cells in the plane culture can be recovered by enzyme treatment such as trypsin and can be transferred to the suspension culture stage.
 一次馴化処理における浮遊培養段階では、多能性幹細胞が浮遊培養しやすい培養条件、例えば、多能性幹細胞が浮遊培養しやすい組成の培地の選択、細胞足場材の除去、これらの組み合わせ等を選択することができる。これにより、平面培養されていた多能性幹細胞が浮遊培養に供される。多能性幹細胞が浮遊培養しやすい組成の浮遊培養段階用培地としては、例えば、1~50%(v/v)又は5~30%(v/v)のノックアウト血清代替物、1~150ng/mLの塩基性線維芽細胞増殖因子(bFGF)、L-グルタミン、還元剤等を含有する培地を挙げることができる。一次馴化処理における浮遊培養段階は、静的な浮遊培養とすることができる。静的な浮遊培養段階に用いられる培養容器としては、マトリゲル等のマトリックス又はマウス胚性線維芽細胞層などの細胞足場材を有しないディッシュを挙げることができる。 In the suspension culture stage in the primary acclimatization treatment, culture conditions that facilitate suspension culture of pluripotent stem cells, for example, selection of a medium having a composition that facilitates suspension culture of pluripotent stem cells, removal of cell scaffold material, a combination thereof, etc. are selected. can do. As a result, the pluripotent stem cells that have been cultivated in a plane are subjected to suspension culture. Examples of the culture medium for the suspension culture stage having a composition that facilitates suspension culture of pluripotent stem cells include 1 to 50% (v / v) or 5 to 30% (v / v) knockout serum substitute, 1 to 150 ng /. Examples thereof include a medium containing mL of basic fibroblast growth factor (bFGF), L-glutamine, a reducing agent, and the like. The suspension culture step in the primary acclimation treatment can be static suspension culture. Examples of the culture vessel used in the static suspension culture step include a dish having no cell scaffolding material such as a matrix such as Matrigel or a mouse embryonic fibroblast layer.
 一次馴化処理における浮遊培養段階は、多能性幹細胞が未分化の状態で増殖する対数増殖期に入るまで継続することができる。細胞の状態によって異なるが、一般に、1ヶ月~2ヶ月程度とすることができる。浮遊培養中の多能性幹細胞のペレット又は単離された多能性幹細胞塊を、少量(例えば、0.2~1mL)の培地中で細胞を上下にピペッティングすることによって、解離することができる。これにより、浮遊培養段階の多能性幹細胞を効率良く大量に得ることができる。未分化状態で多能性幹細胞が対数増殖期に入ったと確認できたときに、一次馴化処理工程を終了し、二次馴化工程に移行する。一次馴化工程によって、一次馴化済み多能性幹細胞を得ることができる。 The suspension culture step in the primary acclimation process can be continued until the pluripotent stem cells enter the logarithmic growth phase in which they proliferate in an undifferentiated state. Although it depends on the state of cells, it can generally be about 1 to 2 months. Pellets of pluripotent stem cells in suspension culture or isolated pluripotent stem cell clusters can be dissociated by pipetting the cells up and down in a small amount (eg, 0.2-1 mL) of medium. it can. As a result, pluripotent stem cells in the suspension culture stage can be efficiently obtained in large quantities. When it is confirmed that the pluripotent stem cells have entered the logarithmic growth phase in the undifferentiated state, the primary acclimation treatment step is terminated and the process proceeds to the secondary acclimation step. By the primary acclimation step, primary acclimated pluripotent stem cells can be obtained.
 二次馴化工程は、一次馴化済み多能性幹細胞に対して、二次馴化用培地を充填した浮遊培養用容器にて浮遊培養が行われる。二次馴化工程で用いられる二次馴化用培地は、一次馴化工程における浮遊培養段階の培地とは異なるものとすることができる。具体的には、一次馴化済み多能性幹細胞に対して、より浮遊培養しやすい傾向を高める組成の培地を選択することができる。 In the secondary acclimation step, the primary acclimated pluripotent stem cells are suspended-cultured in a suspension culture container filled with a secondary acclimation medium. The medium for secondary acclimation used in the secondary acclimation step can be different from the medium in the suspension culture stage in the primary acclimation step. Specifically, it is possible to select a medium having a composition that enhances the tendency for suspension culture to be more likely for the primary conditioned pluripotent stem cells.
 二次馴化用培地としては、プロテアーゼ阻害剤を含有する培地を挙げることができる。
プロテアーゼ阻害剤については後述するものを用いることができる。プロテアーゼ阻害剤を含有する培地については、天然由来の成分を含むことができる。プロテアーゼ阻害剤を含有する培地としては、プロテアーゼ阻害剤を含有する限定培地を使用してもよい。本明細書において「限定培地」とは、人工のものであり、その成分全てが既知である培養培地を意味する。培地には、塩類、栄養素、ミネラル、ビタミン、抗生物質、アミノ酸、核酸、タンパク質などの物質の組み合わせを含む水性培地とすることができる。例えば、DMEM-F12等の合成組織培養培地に、明細書中に記載の各種添加物を添加したものとすることができる。
Examples of the medium for secondary acclimation include a medium containing a protease inhibitor.
As the protease inhibitor, those described later can be used. Mediums containing protease inhibitors can contain naturally occurring components. As the medium containing the protease inhibitor, a limited medium containing the protease inhibitor may be used. As used herein, the term "limited medium" means a culture medium that is artificial and whose components are all known. The medium can be an aqueous medium containing a combination of substances such as salts, nutrients, minerals, vitamins, antibiotics, amino acids, nucleic acids, and proteins. For example, various additives described in the specification can be added to a synthetic tissue culture medium such as DMEM-F12.
 プロテアーゼ阻害剤としては、可逆的プロテアーゼ阻害剤及び不可逆的プロテアーゼ阻害剤を挙げることができ、セリンプロテアーゼの可逆的プロテアーゼ阻害剤及び不可逆的プロテアーゼ阻害剤を挙げることができる。セリンプロテアーゼの可逆的阻害剤としては、フェニルメチルスルホニルフルオリド(PMSF)、GSK3β阻害剤、アルデヒド-CHO、アリールケトン-CO-アリール、トリフルオロメチルケトン-COCF、ケトカルボン酸-COCOOH等が挙げられる。例えば、PMSFの使用濃度は、培地中0.01mM~1mMとすることができる。セリンプロテアーゼの不可逆的阻害剤としては、トリプシン及びトリプシン様セリンプロテアーゼが挙げられ、トシル-L-リシル-クロロメタンヒドロクロリド(TLCK)を挙げることができる。TLCK(CAS 4238-41-9)は、トリプシン及びトリプシン様セリンプロテアーゼの不可逆的阻害剤である。TLCKの使用濃度は、培地中0.05μM~1000μMとすることができ、例えば、5μM~100μMとすることができる。 Examples of the protease inhibitor include a reversible protease inhibitor and an irreversible protease inhibitor, and a reversible protease inhibitor and an irreversible protease inhibitor of serine protease. Reversible inhibitors of serine proteases include phenylmethylsulfonylfluoride (PMSF), GSK3β inhibitors, aldehyde-CHO, arylketone- CO-aryl, trifluoromethylketone-COCF 3 , ketocarboxylic acid-COCOOH and the like. .. For example, the concentration of PMSF used can be 0.01 mM to 1 mM in the medium. Irreversible inhibitors of serine proteases include trypsin and trypsin-like serine proteases, including tosyl-L-lysyl-chloromethanehydrochloride (TLCK). TLCK (CAS 4238-41-9) is an irreversible inhibitor of trypsin and trypsin-like serine proteases. The concentration of TLCK used can be 0.05 μM to 1000 μM in the medium, for example, 5 μM to 100 μM.
 二次馴化用培地には、更に、CHIR99021等のGSK3β阻害剤、WNT3Aポリペプチド、WNT3Aの安定化剤、白血病阻止因子(LIF)、IL6RIL6キメラなどを含むことができる。二次馴化用培地は、ERK1/2阻害剤、JNK阻害剤、p38阻害剤、塩基性線維芽細胞増殖因子(bFGF)等を含まないものとすることができる。二次馴化用培地は、無血清培地とすることができ、1~50%(v/v)又は5~30%(v/v)のノックアウト血清代替物を含むことができる。このような二次馴化用培地としては、例えば、国際公開第2018/015954号(US2019/0284526A)に記載されている限定培養培地を挙げることができる。
 二次馴化用培地としては、上述したものに加えて、Essential 8(Thermo Fisher)、mTeSR1(STEMCELL Technologies社)、StemFitシリーズ(タカラバイオ株式会社)、StemFlex(Thermo Fisher Scientific社)等を挙げることができる。
The medium for secondary acclimation can further contain a GSK3β inhibitor such as CHIR99021, a WNT3A polypeptide, a stabilizer for WNT3A, a leukemia inhibitory factor (LIF), an IL6RIL6 chimera and the like. The medium for secondary acclimation can be free of ERK1 / 2 inhibitors, JNK inhibitors, p38 inhibitors, basic fibroblast growth factor (bFGF) and the like. The secondary acclimation medium can be serum-free and can include 1-50% (v / v) or 5-30% (v / v) knockout serum substitutes. Examples of such a secondary acclimation medium include the limited culture medium described in International Publication No. 2018/015954 (US2019 / 0284526A).
Examples of the medium for secondary acclimation include Essential 8 (Thermo Fisher), mTeSR1 (STEMCELL Technologies), StemFit series (Takara Bio Inc.), StemFlex (Thermo Fisher Scientific), and the like, in addition to those described above. it can.
 二次馴化工程での浮遊培養は、より効率良く細胞数の拡大を行うために、動的な浮遊培養とすることができる。動的な浮遊培養に用いられる浮遊培養用容器としては、培養中の細胞が適切な速度、剪断力、分散度で培地中に分散させることができる容積及び装備を備えたものであれば特に制限はなく、例えば、スピナプラスコ等を挙げることができる。 The suspension culture in the secondary acclimation step can be a dynamic suspension culture in order to expand the number of cells more efficiently. The suspension culture container used for dynamic suspension culture is particularly limited as long as it has a volume and equipment capable of dispersing the cells in culture in the medium at an appropriate speed, shearing force, and dispersion degree. However, for example, Spinna Plasco and the like can be mentioned.
 一次馴化処理の浮遊培養段階で用いられた培地から二次馴化用培地へは、二次馴化用培地の割合を段階的に引き上げるように、2段階以上の数段階で切り替えを行うことができる。培地の組成変更に合わせて、細胞の成育状態に応じたタイミングで、培養容器を、静的な浮遊培養に適する培養容器から動的な浮遊培養に適する培養容器へ変更すればよい。
これにより、一次馴化済み細胞が、穏やかに二次馴化環境に適用することができ、これに伴い、またこの結果、細胞数を効率良く拡大することができる。
The medium used in the suspension culture stage of the primary acclimation treatment can be switched to the secondary acclimation medium in several stages of two or more stages so as to gradually increase the proportion of the secondary acclimation medium. The culture vessel may be changed from a culture vessel suitable for static suspension culture to a culture vessel suitable for dynamic suspension culture at a timing according to the cell growth state in accordance with the change in the composition of the medium.
As a result, the primary conditioned cells can be gently applied to the secondary conditioned environment, and as a result, the number of cells can be efficiently expanded.
 二次馴化工程は、培地交換を行いながら細胞の状態を把握し、未分化状態であることを確認しながら継続すればよい。浮遊培養中の多能性幹細胞のペレット又は単離された多能性幹細胞塊を、少量(例えば、0.2~1mL)の培地中で細胞を上下にピペッティングすることによって、解離することができる。これにより、浮遊培養中の多能性幹細胞を効率良く大量に得ることができる。数週間の二次馴化工程によって、浮遊培養に馴化した二次馴化済み多能性幹細胞を得ることができる。二次馴化済み多能性幹細胞が未分化状態であることは、外観、細胞表面抗原、発現マーカー等によって確認することができる。未分化状態であることは、多能性幹細胞の未分化状態を確認する既知の特徴、例えば、OCT4、Nanog、Tra-1-60、Tra-1-81、SSEA4,SOX2等のマーカーの少なくとも2つ以上の発現状態で確認することができる。 The secondary acclimation step may be continued while grasping the state of the cells while exchanging the medium and confirming that the cells are in an undifferentiated state. Pellets of pluripotent stem cells in suspension culture or isolated pluripotent stem cell clusters can be dissociated by pipetting the cells up and down in a small amount (eg, 0.2-1 mL) of medium. it can. As a result, pluripotent stem cells in suspension culture can be efficiently obtained in large quantities. After several weeks of secondary acclimation, secondary acclimated pluripotent stem cells acclimated to suspension culture can be obtained. The undifferentiated state of the secondary conditioned pluripotent stem cells can be confirmed by appearance, cell surface antigen, expression marker and the like. Being undifferentiated is a known feature that confirms the undifferentiated state of pluripotent stem cells, such as at least 2 of markers such as OCT4, Nanog, Tra-1-60, Tra-1-81, SSEA4, SOX2. It can be confirmed in one or more expression states.
 提供工程では、得られた馴化済み多能性幹細胞は、提供先からの要求に応じて、指定された提供先に馴化実施機関から提供される。上記の通り、提供先は、供給元と同一でも異なっていてもよく、したがって、提供は、提供先からの要求に応じたものであっても、供給元からの要求に応じたものであってもよい。 In the donation process, the obtained acclimatized pluripotent stem cells are provided by the acclimatization executing agency to the designated donor in response to a request from the donor. As mentioned above, the provider may be the same as or different from the supplier, and therefore the offer may be in response to a request from the supplier or a request from the supplier. May be good.
 提供の形態としては、例えば、以下の形態が挙げられる:
(1)供給元から受領した多能性幹細胞に由来する馴化済み多能性幹細胞を、供給元からの要求に応じて、すなわち供給元が必要とするときに、供給元に提供する形態、
(2)供給元から受領した多能性幹細胞に由来する馴化済み多能性幹細胞を、供給元からの要求に応じて、すなわち供給元が必要とするときに、供給元とは異なる提供先に提供する形態、
(3)供給元から受領した多能性幹細胞に由来する馴化済み多能性幹細胞を、提供先からの要求に応じて、すなわち提供先が必要とするときに、提供先に提供する形態。
Examples of the form of provision include the following forms:
(1) A form in which acclimatized pluripotent stem cells derived from pluripotent stem cells received from the supplier are provided to the supplier in response to a request from the supplier, that is, when the supplier requires it.
(2) The conditioned pluripotent stem cells derived from the pluripotent stem cells received from the supplier are sent to a different destination from the supplier in response to a request from the supplier, that is, when the supplier requires it. Form to provide,
(3) A form in which the conditioned pluripotent stem cells derived from the pluripotent stem cells received from the supplier are provided to the donor in response to a request from the donor, that is, when the donor requires it.
 提供先に提供される馴化済み多能性幹細胞は、浮遊培養形態で提供されてもよく、浮遊培養形態から単離し、例えば凍結保存された形態で提供されてもよい。浮遊培養形態で提供する場合には、浮遊培養系から馴化済み多能性幹細胞を回収後、所定の培地と共に提供用容器に充填することができる。提供用容器は、ボトル等の硬質性容器であってもよく、バッグ等の軟質性容器であってもよい。このような提供用容器としては、細胞培養用バイオリアクター等が挙げられる。細胞培養用バイオリアクターは、繰り返し使用可能なものであってもよく、いわゆるシングルユースバイオリアクターであってもよい。多能性幹細胞を馴化実施機関から提供先に移送することができる。移送は、恒温移送、冷蔵移送、冷凍移送等、提供形態に応じた移送形式を適宜選択すればよい。 The acclimatized pluripotent stem cells provided to the recipient may be provided in a suspension culture form, or may be isolated from the suspension culture form and provided, for example, in a cryopreserved form. When provided in the suspension culture form, the acclimatized pluripotent stem cells can be collected from the suspension culture system and then filled in a supply container together with a predetermined medium. The container for provision may be a hard container such as a bottle or a soft container such as a bag. Examples of such a container for provision include a bioreactor for cell culture. The bioreactor for cell culture may be a reusable one, or may be a so-called single-use bioreactor. Pluripotent stem cells can be transferred from the acclimatization executing agency to the delivery destination. For the transfer, a transfer form such as a constant temperature transfer, a refrigerated transfer, a frozen transfer, or the like may be appropriately selected according to the supply form.
 このように本馴化細胞作製方法によれば、浮遊細胞に馴化された多能性幹細胞を利用する供給元又は提供先が自ら、平面培養から浮遊培養までを実施する手間をかけることなく、浮遊培養に馴化された多能性幹細胞を得ることができる。 As described above, according to this method for producing acclimated cells, the supplier or the provider using the pluripotent stem cells acclimated to the suspended cells does not have to take the trouble of carrying out the steps from the planar culture to the suspended culture by themselves. Pluripotent stem cells acclimated to can be obtained.
 換言すれば、浮遊細胞に馴化された多能性幹細胞を、「生け簀」のように維持し、必要なときに必要な細胞数で簡便に用意することができる。例えば、細胞の供給元又は提供先を顧客とした場合に、顧客側で馴化済み多能性幹細胞を準備する手間を省き、顧客側が必要とするときに必要な細胞数で浮遊培養に馴化した多能性幹細胞を提供することができる。 In other words, pluripotent stem cells acclimatized to floating cells can be maintained like a "fish cage" and easily prepared with the required number of cells when needed. For example, when the source or destination of cells is the customer, it is not necessary for the customer to prepare the acclimated pluripotent stem cells, and the number of cells acclimated to the suspension culture is increased when the customer needs it. It is possible to provide pluripotent stem cells.
 得られた浮遊培養に馴化された多能性幹細胞は、未分化能を維持して効率良く増殖することができるため、提供先にとっては、使い勝手の良い多能性幹細胞として種々の態様で利用することができる。このような利用としては、例えば、馴化された多能性幹細胞の未分化能を活用して、所望の細胞へ分化誘導すること、薬剤等のスクリーニングに用いること等が挙げられる。 Since the obtained pluripotent stem cells acclimated to the suspension culture can maintain undifferentiated ability and proliferate efficiently, they can be used in various modes as convenient pluripotent stem cells for the recipient. be able to. Examples of such utilization include utilizing the undifferentiated ability of the acclimatized pluripotent stem cells to induce differentiation into desired cells, and using the cells for screening of drugs and the like.
 本馴化細胞作製方法では、供給元から多能性幹細胞を受領したときに、識別タグ、個別チップ、工程管理番号、バーコード等の他の多能性幹細胞と識別するための識別IDを付与してもよい。識別IDを付与することによって、受領工程から馴化工程、提供工程を通して提供先に馴化済み多能性幹細胞を提供するまで、個別管理をすることができる。 In this method for producing acclimated cells, when pluripotent stem cells are received from the supplier, an identification ID for distinguishing them from other pluripotent stem cells such as an identification tag, an individual chip, a process control number, and a barcode is assigned. You may. By assigning the identification ID, individual management can be performed from the receiving process to the acclimatization step and the provision process until the acclimatized pluripotent stem cells are provided to the recipient.
 本馴化細胞作製方法において、馴化処理を、細胞数をモニタリング(細胞数に関する情報を取得)しながら行うことができ、例えば、一次馴化培養及び二次馴化培養を、所定の細胞数となるように継代しながら、馴化済み細胞を維持し、増殖させることができる。細胞数のモニタリングは、例えば、細胞の倍加時間を考慮し、培地交換時に一定の細胞数に調整して播種することにより、簡便に行うことができる。本馴化細胞作製方法においては、細胞数に関する情報を一例として、馴化処理に供される多能性幹細胞の情報、馴化された多能性幹細胞(馴化済み多能性幹細胞)の情報、及び馴化処理そのものの情報等の馴化処理に関連する様々な情報が取得等されうる。様々な情報の取得等の詳細に関しては後述する。 In this method for producing acclimated cells, the acclimation process can be performed while monitoring the number of cells (acquiring information on the number of cells). For example, the primary acclimation culture and the secondary acclimation culture can be performed so as to have a predetermined number of cells. The acclimatized cells can be maintained and proliferated while subcultured. The number of cells can be easily monitored, for example, by considering the doubling time of cells and adjusting the number of cells to a certain number at the time of medium exchange and seeding. In this method for producing acclimated cells, information on the number of cells is used as an example, information on pluripotent stem cells to be subjected to acclimation treatment, information on acclimated pluripotent stem cells (acclimated pluripotent stem cells), and acclimation treatment. Various information related to the acclimatization process such as the information itself can be acquired. Details such as acquisition of various information will be described later.
 なお、供給元から受領する細胞は、平面培養された多能性幹細胞として本開示に係る馴化細胞作製方法について説明したが、供給元から受領する細胞は、多能性幹細胞に限定されない。本開示の他の態様としては、平面培養された体細胞を供給元から受領することを含んでもよい。この態様では、供給元から細胞を受領した後に、既知の方法に従って細胞をリプログラミングすること、リプログラミングにより得られた多能性幹細胞に対して、平面培養から浮遊培養への移行を可能にするための馴化処理を行うことを含むものであってもよい。 Although the method for producing acclimated cells according to the present disclosure has been described as the cells received from the supplier as pluripotent stem cells cultured in a plane, the cells received from the supplier are not limited to pluripotent stem cells. Another aspect of the disclosure may include receiving plane-cultured somatic cells from a source. In this embodiment, after receiving the cells from the source, the cells are reprogrammed according to a known method, and the pluripotent stem cells obtained by the reprogramming can be transferred from the planar culture to the suspension culture. It may include performing acclimatization processing for the purpose.
 2.様々な情報の取得等
 次に、馴化処理に関連する様々な情報の取得等の詳細について、図1乃至図3を参照しつつ説明する。図1は、一実施形態に係る馴化細胞管理装置100を含む管理システム1の構成の一例を示すブロック図である。図2は、図1に示した馴化細胞管理装置100の機能の一例を模式的に示すブロック図である。図3は、図1に示した馴化処理装置200の機能の一例を模式的に示すブロック図である。
2. 2. Acquisition of various information, etc. Next, details of acquisition of various information related to the acclimatization process, etc. will be described with reference to FIGS. 1 to 3. FIG. 1 is a block diagram showing an example of the configuration of the management system 1 including the acclimation cell management device 100 according to the embodiment. FIG. 2 is a block diagram schematically showing an example of the function of the conditioned cell management device 100 shown in FIG. FIG. 3 is a block diagram schematically showing an example of the function of the acclimation processing device 200 shown in FIG.
 なお、本明細書において、アプリケーションという用語は、ソフトウェア又はプログラムと称呼されるものであってもよく、コンピュータに対する指令であって、或る種の結果を得ることができるように組み合わされたものであればよい。 It should be noted that, in the present specification, the term application may be referred to as software or program, and is a command to a computer, which is combined so as to obtain a certain result. All you need is.
 管理システム1は、図1に示すように、馴化細胞管理装置100と、馴化処理装置200と、から主に構成されている。馴化細胞管理装置100と馴化処理装置200とは、通信回線を介して様々な電子情報を送受信可能となっている。また、馴化細胞管理装置100は、1又は複数の提供先サーバ装置300とも、通信回線を介して様々な電子情報を送受信可能としてもよい。なお、図1には、一例として、提供先が3つ存在する場合が想定されており、当該3つの提供先の各々の提供先サーバ装置300(提供先サーバ装置300A、提供先サーバ装置300B、及び提供先サーバ装置300C)と通信回線を介して接続されている。以下、管理システム1を構成する、馴化細胞管理装置100及び馴化処理装置200の詳細について説明する。 As shown in FIG. 1, the management system 1 is mainly composed of the acclimation cell management device 100 and the acclimation processing device 200. The acclimation cell management device 100 and the acclimation processing device 200 can transmit and receive various electronic information via a communication line. Further, the acclimatization cell management device 100 may be capable of transmitting and receiving various electronic information via a communication line with one or a plurality of destination server devices 300. In addition, in FIG. 1, as an example, it is assumed that there are three providing destinations, and the providing destination server device 300 (providing destination server device 300A, providing destination server device 300B, each of the three providing destinations). And is connected to the provider server device 300C) via a communication line. Hereinafter, the details of the acclimation cell management device 100 and the acclimation processing device 200 constituting the management system 1 will be described.
 2-1.馴化細胞管理装置100
 馴化細胞管理装置100は、馴化処理装置200と通信回線を介して接続される端末装置又はサーバ装置である。馴化細胞管理装置100は、1つの端末装置又はサーバ装置であってもよいし、負荷を分散させることを目的として、複数の端末装置又はサーバ装置から構成されるようにしてもよい。端末装置又はサーバ装置としての馴化細胞管理装置100は、ハードウェアとして、相互にデータバス及び/又は制御バスによって接続される中央処理装置、主記憶装置、入出力インタフェイス、入力装置、補助記憶装置、出力装置、等を主に備え、後述する様々な情報処理を実行することができる。
2-1. Acclimated cell management device 100
The acclimation cell management device 100 is a terminal device or a server device connected to the acclimation processing device 200 via a communication line. The conditioned cell management device 100 may be one terminal device or server device, or may be composed of a plurality of terminal devices or server devices for the purpose of distributing the load. The acclimatized cell management device 100 as a terminal device or a server device is a central processing unit, a main storage device, an input / output interface, an input device, an auxiliary storage device, which are connected to each other by a data bus and / or a control bus as hardware. , An output device, etc., and can execute various information processing described later.
 中央処理装置は、「CPU」と称され、主記憶装置に記憶されている命令及びデータに対して演算を行い、その演算の結果を主記憶装置に記憶させることができる。さらに、中央処理装置は、入出力インタフェイスを介して、入力装置、補助記憶装置及び出力装置等を制御することができる。馴化細胞管理装置100は、1又はそれ以上の中央処理装置を含むことが可能である。 The central processing unit is called a "CPU", and can perform calculations on instructions and data stored in the main storage device, and store the results of the calculations in the main storage device. Further, the central processing unit can control an input device, an auxiliary storage device, an output device, and the like via an input / output interface. The conditioned cell management device 100 can include one or more central processing units.
 主記憶装置は、「メモリ」と称され、入力装置、補助記憶装置及び入出力インタフェイスを介して受信した命令及びデータ、並びに、中央処理装置の演算結果等を記憶することができる。主記憶装置は、RAM(ランダムアクセスメモリ)、ROM(リードオンリーメモリ)及び/又はフラッシュメモリ等をこれらに限定することなく含むことができる。 The main storage device is called a "memory" and can store commands and data received via an input device, an auxiliary storage device, and an input / output interface, as well as calculation results of a central processing unit. The main storage device may include, without limitation, RAM (random access memory), ROM (read-only memory) and / or flash memory and the like.
 補助記憶装置は、主記憶装置よりも大きな容量を有する記憶装置である。補助記憶装置は、特定のアプリケーション、具体的には、馴化細胞管理用アプリケーション、ウェブブラウザアプリケーション等を構成する命令及びデータ(コンピュータプログラム)を記憶することができる。さらに、補助記憶装置は、中央処理装置により制御されることにより、これらの命令及びデータ(コンピュータプログラム)を、入出力インタフェイスを介して主記憶装置に送信することができる。補助記憶装置は、磁気ディスク装置及び/又は光ディスク装置等をこれらに限定することなく含むことができる。 The auxiliary storage device is a storage device having a larger capacity than the main storage device. The auxiliary storage device can store instructions and data (computer programs) that constitute a specific application, specifically, an acclimation cell management application, a web browser application, and the like. Further, the auxiliary storage device can transmit these instructions and data (computer program) to the main storage device via the input / output interface by being controlled by the central processing unit. The auxiliary storage device may include, but is not limited to, a magnetic disk device and / or an optical disk device and the like.
 入力装置は、外部からデータを取り込む装置であって、タッチパネル、ボタン、キーボード、マウス及び/又はセンサ等をこれらに限定することなく含むことができる。 The input device is a device that takes in data from the outside, and can include a touch panel, a button, a keyboard, a mouse, and / or a sensor without limitation.
 出力装置は、ディスプレイ装置、タッチパネル及び/又はプリンタ装置等をこれらに限定することなく含むことができる。 The output device can include, without limitation, a display device, a touch panel and / or a printer device, and the like.
 このようなハードウェア構成にあっては、中央処理装置が、補助記憶装置に記憶された特定のアプリケーションを構成する命令及びデータ(コンピュータプログラム)を順次主記憶装置にロードし、ロードした命令及びデータを演算することができる。これにより、中央処理装置は、入出力インタフェイスを介して出力装置を制御し、或いはまた、入出力インタフェイス及び通信回線を介して、馴化処理装置200、場合によっては1又は複数の提供先サーバ装置300との間で、様々な情報の送受信を行うことができる。 In such a hardware configuration, the central processing unit sequentially loads the instructions and data (computer programs) that make up a specific application stored in the auxiliary storage device into the main storage device, and the loaded instructions and data. Can be calculated. Thereby, the central processing unit controls the output device via the input / output interface, or also via the input / output interface and the communication line, the acclimation processing unit 200, and in some cases one or more destination servers. Various information can be transmitted and received to and from the device 300.
 馴化細胞管理装置100には、馴化処理に関連する様々な情報を取得するための特定のアプリケーション(例えば、前述の馴化細胞管理用アプリケーション)がインストールされる。これにより、馴化細胞管理装置100は、そのアプリケーションを実行することにより、馴化処理に関連する様々な情報の取得等を実行することができる。 A specific application for acquiring various information related to the acclimatization process (for example, the above-mentioned acclimatization cell management application) is installed in the acclimatization cell management device 100. As a result, the acclimatization cell management device 100 can acquire various information related to the acclimatization process by executing the application.
 前述のハードウェア構成を有する馴化細胞管理装置100は、図2に示すように、第1通信部110及び記憶部120を主に含むことができる。また、馴化細胞管理装置100が、1又は複数の提供先サーバ装置300と通信回線を介して接続される場合においては、さらに判定部130を含むことができる。さらにまた、馴化細胞管理装置100が特に端末装置である場合においては、さらに表示部140、及び第1ユーザインタフェイス部150を含むことができる。 As shown in FIG. 2, the acclimation cell management device 100 having the above-mentioned hardware configuration can mainly include the first communication unit 110 and the storage unit 120. Further, when the acclimatized cell management device 100 is connected to one or a plurality of destination server devices 300 via a communication line, the determination unit 130 can be further included. Furthermore, when the acclimatization cell management device 100 is a terminal device in particular, the display unit 140 and the first user interface unit 150 can be further included.
 第1通信部110は、通信回線を介して、馴化処理装置200から、初期細胞情報、馴化処理情報、及び馴化済み多能性幹細胞情報を含む様々な情報からなる群より選択される少なくとも一つの情報を受信して、受信した情報を記憶部120へ送信することができる。なお、初期細胞情報、馴化処理情報、及び馴化済み多能性幹細胞情報の詳細については後述する。 The first communication unit 110 is at least one selected from a group consisting of various information including initial cell information, acclimation processing information, and acclimated pluripotent stem cell information from the acclimation processing device 200 via a communication line. The information can be received and the received information can be transmitted to the storage unit 120. The details of the initial cell information, the acclimatization processing information, and the acclimatized pluripotent stem cell information will be described later.
 さらに、馴化細胞管理装置100が、1又は複数の提供先サーバ装置300と通信回線を介して接続される場合、第1通信部110は、通信回線を介して、提供先サーバ装置300から、提供先(顧客)が要求する(希望する)馴化済み多能性幹細胞に関する要求情報(提供先要求情報)を受信して、受信した提供先要求情報を記憶部120へ送信することができる。 Further, when the acclimatized cell management device 100 is connected to one or a plurality of destination server devices 300 via a communication line, the first communication unit 110 is provided by the provider server device 300 via the communication line. It is possible to receive the request information (delivery destination request information) regarding the (desired) conditioned pluripotent stem cell requested by the destination (customer) and transmit the received provision destination request information to the storage unit 120.
 なお、提供先要求情報は、その提供先の法人名、個人名等に関する識別情報に加えて、馴化済み多能性幹細胞の細胞数に関する情報、及び馴化済み多能性幹細胞の馴化の程度に関する情報(例えば、一次馴化処理のみを希望する、一次馴化処理及び二次馴化処理の両方を希望する、一次馴化処理及び二次馴化処理の一部だけを希望する、等の情報が含まれる)を一例として含むことができる。また、これらの情報に加えて、提供先要求情報には、馴化処理に関する培養条件(培地、培養容器、温度、pH、播種密度、継代数、継代条件等に関する条件等)に関する情報、馴化済み多能性幹細胞の目的とされる部位(例えば、網膜、心筋、神経、等)に関する情報、提供形態(例えば、浮遊培養形態、冷結保存形態、等)に関する情報、及び提供先の利用形態(所望の細胞への分化誘導、薬剤等のスクリーニング、等)に関する情報等を制限なく含めることができる。 The provider request information includes information on the number of acclimated pluripotent stem cells and information on the degree of acclimation of the acclimated pluripotent stem cells, in addition to identification information on the corporate name, personal name, etc. of the provider. (For example, information such as requesting only the primary acclimation process, requesting both the primary acclimation process and the secondary acclimation process, requesting only a part of the primary acclimation process and the secondary acclimation process, etc.) is included as an example. Can be included as. In addition to this information, the provider request information includes information on culture conditions related to acclimatization (medium, culture vessel, temperature, pH, seeding density, number of subcultures, conditions related to subculture conditions, etc.), and acclimatized. Information on the target site (eg, retina, myocardium, nerve, etc.) of pluripotent stem cells, information on the donation form (eg, suspension culture form, cold storage form, etc.), and usage form of the donation destination (for example, Information on induction of differentiation into desired cells, screening of drugs, etc.) can be included without limitation.
 なお、馴化処理によって得られた馴化済み多能性幹細胞について、馴化処理後に馴化済み多能性幹細胞を所定の細胞へ分化誘導する分化誘導処理を行う場合において、目的とする分化細胞の種類に関する情報、及び遺伝子検査等のオプション情報等を提供先が要求する場合、これらの情報も提供先要求情報に含めることができる。また、得られた細胞に対して指定された安全性試験を実施する安全性確認処理を行う場合であって、不純物試験、無菌・マイコプラスマ否定試験、エンドトキシン試験等の安全性に関する情報を提供先が要求する場合、これらの情報も提供先要求情報に含めることができる。さらにまた、提供先へ指定細胞(馴化済み多能性幹細胞)を移送する場合において、製品状態、搬送情報等の出荷管理情報を提供先が要求する場合、当該出荷管理情報も提供先要求情報に含めることができる。 Information on the type of differentiated cell of interest in the case of performing a differentiation-inducing treatment for inducing differentiation of the acclimated pluripotent stem cell into a predetermined cell after the acclimation treatment on the acclimated pluripotent stem cell obtained by the acclimation treatment. , And when the provider requests optional information such as genetic testing, such information can also be included in the provider request information. In addition, when performing a safety confirmation process to carry out a designated safety test on the obtained cells, the provider provides information on safety such as impurity test, sterility / mycoplasma denial test, endotoxin test, etc. When requesting, this information can also be included in the destination request information. Furthermore, when transferring designated cells (acclimated pluripotent stem cells) to the delivery destination, if the delivery destination requests shipping management information such as product status and transport information, the shipping management information is also included in the delivery destination request information. Can be included.
 ところで、前述の通信回線とは、有線、無線LAN、インターネット等をこれらに限定することなく含むことができる。 By the way, the above-mentioned communication line can include wired, wireless LAN, the Internet, etc. without limitation.
 また、馴化細胞管理装置100が、1又は複数の提供先サーバ装置300と通信回線を介して接続される場合において、第1通信部110は、馴化処理装置200から受信した初期細胞情報、馴化処理情報、及び馴化済み多能性幹細胞情報を含む様々な情報を、提供先(提供先のサーバ装置300)に送信することができる。これにより、提供先(顧客)は、単に物理的に馴化済み多能性幹細胞を提供されるだけでなく、馴化処理に関連する情報、とりわけ馴化済み多能性幹細胞そのものに関連する情報をも提供を受けることが可能となる。したがって、提供先にとっては信頼性が高く、且つ再現性の高い馴化済み多能性幹細胞の提供を受けることができる。 Further, when the acclimatization cell management device 100 is connected to one or a plurality of destination server devices 300 via a communication line, the first communication unit 110 receives initial cell information and acclimatization processing from the acclimatization processing device 200. Various information including the information and the acclimatized pluripotent stem cell information can be transmitted to the providing destination (the server device 300 of the providing destination). As a result, the recipient (customer) is not only provided with physically acclimatized pluripotent stem cells, but also provides information related to the acclimatization process, especially information related to the acclimatized pluripotent stem cells themselves. It will be possible to receive. Therefore, it is possible to receive the donated pluripotent stem cells that are highly reliable and highly reproducible for the recipient.
 記憶部120は、第1通信部110から受信した情報を記憶することができる。ここで、記憶部120は、第1通信部110から受信する様々な情報を、提供先、多能性幹細胞の種類等に応じて分類して記憶することができる。この場合において、例えば、供給元から受領した多能性幹細胞に、前述のとおり識別IDが付与される場合には、第1通信部110が馴化処理装置200から受信する様々な情報の各々に、識別IDが関連付けられるようにしておくことで、記憶部120は、様々な情報を、識別IDごとに管理、記憶することができる。さらに、記憶部120は、後述する第1ユーザインタフェイス部150を介して入力される様々な情報、及び種々の設定に関する情報等についても記憶することもできる。 The storage unit 120 can store the information received from the first communication unit 110. Here, the storage unit 120 can classify and store various information received from the first communication unit 110 according to the destination, the type of pluripotent stem cell, and the like. In this case, for example, when the pluripotent stem cells received from the supplier are given the identification ID as described above, each of the various information received from the acclimatization processing device 200 by the first communication unit 110 is By so that the identification IDs are associated with each other, the storage unit 120 can manage and store various information for each identification ID. Further, the storage unit 120 can also store various information input via the first user interface unit 150, which will be described later, and information related to various settings.
判定部130は、馴化細胞管理装置100が、1又は複数の提供先サーバ装置300と通信回線を介して接続される場合において、前述のとおり記憶部120に記憶された、馴化済み多能性幹細胞に関する提供先要求情報と、馴化済み多能性幹細胞情報とを記憶部120から読み出した上で両者を比較して、両者間に相違があるか否かを判定することができる。具体的には、例えば、提供先要求情報として馴化済み多能性幹細胞の細胞数に関する情報(例えば、「X個」との情報)と、馴化処理装置200から送信された馴化済み多能性幹細胞情報としての馴化済み多能性幹細胞の細胞数に関する情報(例えば、「Y個」との情報)とを比較して、XとYが一致する(又はXとYの差が予め決められた範囲内にある)場合には両者に相違はないと判定し、XとYとが一致しない(又はXとYの差が予め決められた範囲を超えている)場合には両者に相違があると判定する。 When the acclimation cell management device 100 is connected to one or a plurality of destination server devices 300 via a communication line, the determination unit 130 is a acclimated pluripotent stem cell stored in the storage unit 120 as described above. It is possible to determine whether or not there is a difference between the two after reading out the destination request information regarding the above and the acclimatized pluripotent stem cell information from the storage unit 120 and comparing the two. Specifically, for example, information on the number of cells of the acclimatized pluripotent stem cells (for example, information of "X") as the destination request information and the acclimatized pluripotent stem cells transmitted from the acclimatization processing apparatus 200. Compared with information on the number of acclimatized pluripotent stem cells as information (for example, information with "Y"), X and Y match (or the difference between X and Y is a predetermined range. If (inside), it is judged that there is no difference between the two, and if X and Y do not match (or the difference between X and Y exceeds a predetermined range), there is a difference between the two. judge.
 なお、判定部130による提供先要求情報と馴化済み多能性幹細胞情報との比較、及び両者の相違の有無の判定は、細胞数に着目することに限定される必要はなく、他の詳細な情報に置換されてもよいし、他の詳細な情報と組み合わせて実行されてもよい。また、提供先要求情報が、例えば、単に、馴化済み多能性幹細胞情報としての馴化済み多能性幹細胞の細胞数に関する情報の提出を求める場合(つまり、提供先は、単に、提供先へ馴化済み多能性幹細胞の細胞数を報告する旨を要求するのみであり、細胞数に関する具体的な要求提示は提供先からなされない場合)には、判定部130は、記憶部120に記憶された様々な情報の中から、馴化済み多能性幹細胞情報としての馴化済み多能性幹細胞の細胞数に関する情報が格納(記憶)されているかどうかに基づいて、提供先要求情報に対応する情報の有無を判定することができる。また、提供先要求情報が、例えば、単に、初期細胞情報又は馴化処理情報に関する情報の提出を求める場合(つまり、提供先は、単に提供先へ初期細胞情報又は馴化処理情報を報告する旨を要求するのみであり、初期細胞情報又は馴化処理情報に関する具体的な要求提示は提供先からなされない場合)においても、同様に、判定部130は、記憶部120に記憶された様々な情報の中から、初期細胞情報又は馴化処理情報が格納(記憶)されているどうかに基づいて、提供先要求情報に対応する情報の有無を判定することができる。 The comparison between the provider request information and the acclimatized pluripotent stem cell information by the determination unit 130 and the determination of the presence or absence of a difference between the two need not be limited to focusing on the number of cells, and other details are given. It may be replaced with information or executed in combination with other detailed information. Further, when the destination request information simply requests the submission of information regarding the cell number of the acclimatized pluripotent stem cells as the acclimatized pluripotent stem cell information (that is, the destination simply acclimatizes to the destination). The determination unit 130 is stored in the storage unit 120 when only requesting that the cell number of the pluripotent stem cells be reported and the specific request regarding the cell number is not presented by the provider). Whether or not there is information corresponding to the destination request information based on whether or not information on the number of cells of the acclimatized pluripotent stem cells as the acclimatized pluripotent stem cell information is stored (stored) from various information. Can be determined. Further, when the provider request information simply requests the submission of information regarding the initial cell information or the acclimatization processing information (that is, the provider simply requests the provider to report the initial cell information or the acclimatization processing information). Similarly, in the case where a specific request for the initial cell information or the acclimation processing information is not presented by the provider), the determination unit 130 also selects from various information stored in the storage unit 120. , The presence or absence of information corresponding to the provider request information can be determined based on whether the initial cell information or the acclimatization processing information is stored (stored).
 提供先要求情報と前記馴化済み多能性幹細胞情報と間に相違があるか否かに関する判定部130の判定結果は、表示部140に送信されうる。これにより、馴化細胞管理装置100の管理者は、その判定結果に基づいて、提供先の要求する馴化済み多能性幹細胞を手配できているか否かを容易に確認することができる。つまり、馴化細胞管理装置100の管理者は、提供先の要求に応じて馴化処理が適切に実行されたどうかを管理することが可能となる。 The determination result of the determination unit 130 regarding whether or not there is a difference between the provision destination request information and the acclimatized pluripotent stem cell information can be transmitted to the display unit 140. As a result, the administrator of the acclimatized cell management device 100 can easily confirm whether or not the acclimatized pluripotent stem cells requested by the provider can be arranged based on the determination result. That is, the administrator of the acclimatization cell management device 100 can manage whether or not the acclimatization process is appropriately executed according to the request of the provider.
 表示部140は、前述のとおり、判定部130による判定結果を表示することができる。表示部140としては、一般的なモニター画面を用いることができ、馴化細胞管理装置100の管理者が視認可能な場所に配置される。なお、例えば、馴化細胞管理装置100をサーバ装置と捉える場合においては、必ずしも馴化細胞管理装置100に表示部140が設けられている必要はなく、管理者が保有する別の端末装置(例えば、スマートフォン等)から通信回線を介して馴化細胞管理装置100に接続可能としておくことで、判定部130による判定結果を、管理者が保有する別の端末装置の表示画面に表示されるようにしてもよい。 As described above, the display unit 140 can display the determination result by the determination unit 130. A general monitor screen can be used as the display unit 140, and the display unit 140 is arranged in a place where the administrator of the acclimation cell management device 100 can see. For example, when the acclimatized cell management device 100 is regarded as a server device, the acclimatized cell management device 100 does not necessarily have to be provided with the display unit 140, and another terminal device owned by the administrator (for example, a smartphone). Etc.), the determination result by the determination unit 130 may be displayed on the display screen of another terminal device owned by the administrator by making it possible to connect to the acclimation cell management device 100 via the communication line. ..
 第1ユーザインタフェイス部150は、馴化細胞管理装置100の様々な設定を、管理者の操作を介して入力することができる。例えば、第1ユーザインタフェイス部150は、判定部130が提供先要求情報と馴化済み多能性幹細胞情報とが相違するか否かを判定する場合における前述のXとYの差に係る「予め決められた範囲」、判定部130が判定を実行する際に着目する詳細な情報(細胞数等の情報)の設定等を、管理者の操作を介して入力することができる。また、第1ユーザインタフェイス部150は、記憶部120に記憶される様々な情報の仕訳ルール(分類ルール)等を、管理者の操作を介して入力することができる。さらにまた、第1ユーザインタフェイス部150は、第1通信部110を介して馴化処理装置200から受信する情報以外の情報を、管理者の操作を介して入力することができる。 The first user interface unit 150 can input various settings of the acclimatized cell management device 100 via the operation of the administrator. For example, the first user interface unit 150 relates to the above-mentioned difference between X and Y when the determination unit 130 determines whether or not the provision destination request information and the acclimatized pluripotent stem cell information are different from each other. The "determined range", the setting of detailed information (information such as the number of cells) to be focused on when the determination unit 130 executes the determination, and the like can be input via the operation of the administrator. Further, the first user interface unit 150 can input journalizing rules (classification rules) and the like of various information stored in the storage unit 120 via the operation of the administrator. Furthermore, the first user interface unit 150 can input information other than the information received from the acclimatization processing device 200 via the first communication unit 110 via the operation of the administrator.
 ここで、第1通信部110を介して馴化処理装置200から受信する情報以外の情報であって、第1ユーザインタフェイス部150を介して入力される情報には、例えば、以下の情報の少なくとも1つを制限なく含めることができる。なお、以下に例示される各情報は、後述する第2ユーザインタフェイス部240を介して馴化処理装置200に入力された後、該馴化処理装置200から第1通信部110を介して馴化細胞管理装置100に送信されるように構成してもよい。
(1)馴化処理によって得られた馴化済み多能性幹細胞について、馴化処理後に馴化済み多能性幹細胞を所定の細胞へ分化誘導する分化誘導処理を行う場合における、目的とする分化細胞の種類に関する情報、及び、必要に応じて遺伝子検査等のオプション情報。
(2)得られた細胞に対して指定された安全性試験を実施する安全性確認処理を行う場合における、不純物試験、無菌・マイコプラスマ否定試験、エンドトキシン試験等の安全性に関する情報。
(3)提供先へ指定細胞(馴化済み多能性幹細胞)を移送する場合における、製品状態、搬送情報等の出荷管理情報。
Here, the information other than the information received from the acclimatization processing device 200 via the first communication unit 110 and input via the first user interface unit 150 includes, for example, at least the following information. One can be included without limitation. Each piece of information exemplified below is input to the acclimation processing device 200 via the second user interface unit 240 described later, and then the acclimation cell management is performed from the acclimation processing device 200 via the first communication unit 110. It may be configured to be transmitted to the device 100.
(1) Regarding the type of the target differentiated cell in the case of performing the differentiation induction treatment for inducing the differentiation of the acclimated pluripotent stem cell into a predetermined cell after the acclimation treatment with respect to the conditioned pluripotent stem cell obtained by the acclimation treatment. Information and optional information such as genetic testing as needed.
(2) Information on safety such as impurity test, sterility / mycoplasma denial test, endotoxin test, etc. when performing safety confirmation processing to carry out the specified safety test on the obtained cells.
(3) Shipping management information such as product status and transport information when the designated cells (acclimated pluripotent stem cells) are transferred to the destination.
 2-2.馴化処理装置200
 馴化処理装置200は、前述のとおり馴化細胞管理装置100と通信回線を介して接続されており、様々な情報を取得し、取得した様々な情報をリアルタイムで馴化細胞管理装置100へ送信することができる。
2-2. Habituation processing device 200
As described above, the acclimation processing device 200 is connected to the acclimation cell management device 100 via a communication line, and can acquire various information and transmit the acquired various information to the acclimation cell management device 100 in real time. it can.
 馴化処理装置200は、図3に示すように、馴化処理実行部210、センサ部220、第2通信部230、及び第2ユーザインタフェイス部240を主に含むことができる。 As shown in FIG. 3, the acclimation processing device 200 can mainly include a acclimation processing execution unit 210, a sensor unit 220, a second communication unit 230, and a second user interface unit 240.
 馴化処理実行部210は、一次馴化処理及び二次馴化処理を実行する全てのハードウェアを含むことができる。具体的には、馴化処理実行部210は、一次馴化処理を実行するために用いられる培養容器、二次馴化処理を実行する浮遊培養用の培養容器、攪拌部材、培養装置、培地供給装置等を制限なく含むことができる。 The acclimation process execution unit 210 can include all hardware that executes the primary acclimation process and the secondary acclimation process. Specifically, the acclimation process execution unit 210 includes a culture vessel used for executing the primary acclimation process, a culture container for suspension culture for executing the secondary acclimation process, a stirring member, a culture device, a medium supply device, and the like. Can be included without limitation.
 センサ部220は、ハードウェアとして、馴化処理装置200内に設けられて、様々な情報を取得することができる。センサ部220は、例えば、温度センサ、画像センサ等の様々なセンサ類を含むことができる。センサ部220は、供給元から受領した平面培養された多能性幹細胞(馴化処理に供される前の多能性幹細胞)に関する初期細胞情報、多能性幹細胞に対し、平面培養から浮遊培養への移行を可能にするための馴化処理に関する馴化処理情報、馴化処理によって生成される馴化済み多能性幹細胞に関する馴化済み多能性幹細胞情報等の1又は複数の情報を一例として取得することができる。 The sensor unit 220 is provided in the acclimation processing device 200 as hardware and can acquire various information. The sensor unit 220 can include various sensors such as a temperature sensor and an image sensor, for example. The sensor unit 220 changes the initial cell information about the flat-cultured pluripotent stem cells (pluripotent stem cells before being subjected to the acclimatization treatment) received from the supplier, and the pluripotent stem cells from the flat culture to the suspension culture. It is possible to obtain one or more pieces of information such as acclimation processing information regarding acclimation processing and acclimated pluripotent stem cell information regarding acclimated pluripotent stem cells generated by the acclimation process as an example. ..
 ここで、初期細胞情報とは、馴化処理に供される前の多能性幹細胞の細胞由来(ドナー)及び細胞種(骨髄、臍帯血、皮膚繊維芽、脂肪、等)に関する情報を含むことができる。このような初期細胞情報は、馴化処理に供される前の多能性幹細胞を収容する培養容器にバーコードや個別チップ内に識別IDに関連付けて入力される構成を一例として採用することができる。これにより、その培養容器が馴化処理装置200内の所定位置に載置されると、センサ部220がバーコード、個別チップ等に入力されている初期細胞情報を読み出すことで、センサ部220が初期細胞情報を取得することができる。 Here, the initial cell information may include information on the cell origin (donor) and cell type (bone marrow, cord blood, skin fibroblast, fat, etc.) of pluripotent stem cells before being subjected to acclimation treatment. it can. As an example, such initial cell information can be adopted as a configuration in which a barcode or an individual chip is input in association with an identification ID in a culture vessel containing pluripotent stem cells before being subjected to acclimation treatment. .. As a result, when the culture vessel is placed at a predetermined position in the acclimatization processing device 200, the sensor unit 220 reads out the initial cell information input to the barcode, the individual chip, etc., so that the sensor unit 220 is initially set. Cell information can be acquired.
 馴化処理情報は、一次馴化処理に関する一次馴化処理情報と、二次馴化処理に関する二次馴化処理情報を含むことができる。一次馴化処理情報には、一次馴化処理に用いられる培地に関する情報、一次馴化処理に関する培養条件(培養容器の体積、播種密度、温度、pH、継代数、継代条件、等)に関する情報が含まれうる。二次馴化処理情報には、二次馴化処理に用いられる培地に関する情報、二次馴化処理に関する培養条件(培養容器の体積、温度、pH、継代数、攪拌速度、)に関する情報が含まれうる。馴化処理情報は、pHセンサ等のセンサ部220によって取得されてもよいし、例えば、培養容器の体積、継代数等の情報は、第2ユーザインタフェイス部240を介して管理者によって別途入力されるようにすればよい。 The acclimation processing information can include primary acclimation processing information regarding the primary acclimation processing and secondary acclimation processing information regarding the secondary acclimation processing. The primary acclimation processing information includes information on the medium used for the primary acclimation treatment and information on the culture conditions (culture container volume, seeding density, temperature, pH, number of passages, passage conditions, etc.) related to the primary acclimation treatment. sell. The secondary acclimation treatment information may include information on the medium used in the secondary acclimation treatment and information on the culture conditions (volume, temperature, pH, passage number, stirring speed, etc. of the culture vessel) regarding the secondary acclimation treatment. The acclimatization processing information may be acquired by a sensor unit 220 such as a pH sensor, and for example, information such as the volume of the culture vessel and the number of passages is separately input by the administrator via the second user interface unit 240. You can do it.
 馴化済み多能性幹細胞情報は、一次馴化処理済みの多能性幹細胞に関する一次馴化済み多能性幹細胞情報、及び、二次馴化処理済みの多能性幹細胞に関する二次馴化済み多能性幹細胞情報を含むことができる。一次馴化済み多能性幹細胞情報には、一次馴化処理済の多能性幹細胞の細胞数、細胞形態の特徴等に関する情報が含まれうる。二次馴化済み多能性幹細胞情報には、二次馴化処理済の多能性幹細胞の細胞数、細胞形態の特徴等に関する情報が含まれうる。また、一次馴化済み多能性幹細胞情報には、一次馴化処理済の多能性幹細胞に係る生化学的情報が含まれてもよい。同様に、二次馴化済み多能性幹細胞情報には、二次馴化処理済の多能性幹細胞に係る生化学的情報が含まれてもよい。 The acclimated pluripotent stem cell information includes primary conditioned pluripotent stem cell information on primary conditioned pluripotent stem cells and secondary conditioned pluripotent stem cell information on secondary conditioned pluripotent stem cells. Can be included. The primary conditioned pluripotent stem cell information may include information on the number of cells of the primary conditioned pluripotent stem cells, cell morphological characteristics, and the like. The secondary conditioned pluripotent stem cell information may include information on the number of cells of the secondary conditioned pluripotent stem cells, cell morphological characteristics, and the like. In addition, the primary conditioned pluripotent stem cell information may include biochemical information relating to the primary conditioned pluripotent stem cells. Similarly, the secondary conditioned pluripotent stem cell information may include biochemical information relating to the secondary conditioned pluripotent stem cells.
 ここで、一次馴化処理済の多能性幹細胞の細胞数、及び二次馴化処理済の多能性幹細胞の細胞数は、画像センサとしてのセンサ部220によって取得することができるし、他の方法に基づいて取得することもできる。同様に、細胞形態の特徴についても、画像センサとしてのセンサ部220によって取得することができる。なお、細胞形態の特徴に関する情報とは、例えば、細胞塊の数、サイズ、細胞塊の形状、細胞表面の形状等の情報を含むことができる。 Here, the number of cells of the pluripotent stem cell that has undergone the primary acclimation treatment and the number of cells of the pluripotent stem cell that has undergone the secondary acclimation treatment can be obtained by the sensor unit 220 as an image sensor, or by another method. It can also be obtained based on. Similarly, the characteristics of the cell morphology can also be acquired by the sensor unit 220 as an image sensor. The information regarding the characteristics of the cell morphology can include, for example, information such as the number and size of the cell mass, the shape of the cell mass, and the shape of the cell surface.
 センサ部220は、馴化処理装置200をリアルタイムでモニタリングすることが可能となっているため、前述のとおり例示的に列挙した様々な情報をリアルタイムで入手することができる。なお、センサ部220は、入手した様々な情報を、全て第2通信部230へ送信することができる。 Since the sensor unit 220 can monitor the acclimation processing device 200 in real time, various information exemplarily listed as described above can be obtained in real time. The sensor unit 220 can transmit all the obtained various information to the second communication unit 230.
 また、センサ部220は、馴化処理実行部210によって実行される馴化処理の状況を画像情報として又は動画情報として取得することもできる。 Further, the sensor unit 220 can also acquire the status of the acclimatization process executed by the acclimatization process execution unit 210 as image information or moving image information.
 第2通信部230は、センサ部220から受信した様々な情報を、リアルタイムで馴化細胞管理装置100(の第1通信部110)へ送信することができる。これにより、管理者は、馴化細胞管理装置100の表示部140を介して、馴化処理がどのように実行されているかをリアルタイムで管理することが可能となる。より詳細には、管理者は、馴化細胞管理装置100の表示部140を介して、様々な情報をリアルタイムで管理、監視することで、馴化処理工程上に何らかの問題が生じた場合であっても、即時に対応策を講じることができる。 The second communication unit 230 can transmit various information received from the sensor unit 220 to the acclimation cell management device 100 (the first communication unit 110) in real time. As a result, the administrator can manage in real time how the acclimation process is executed via the display unit 140 of the acclimation cell management device 100. More specifically, the administrator manages and monitors various information in real time via the display unit 140 of the acclimatization cell management device 100, so that even if some problem occurs in the acclimatization process. , You can take immediate action.
 第2ユーザインタフェイス部240は、馴化処理実行部210によって実行される馴化処理に関する様々な設定を、管理者の操作を介して入力することができる。また、第2ユーザインタフェイス部240は、センサ部220では取得できない前述の初期細胞情報、馴化処理情報、馴化済み多能性幹細胞情報等(例えば、蛍光染色法に基づいて取得しうる、一次馴化処理済の多能性幹細胞の細胞数、及び二次馴化処理済の多能性幹細胞の細胞数)を、管理者の操作を介して入力することができる。 The second user interface unit 240 can input various settings related to the acclimatization process executed by the acclimatization process execution unit 210 via the operation of the administrator. Further, the second user interface unit 240 can acquire the above-mentioned initial cell information, acclimatization processing information, acclimatized pluripotent stem cell information and the like (for example, primary acclimatization that can be acquired based on the fluorescent staining method) that cannot be acquired by the sensor unit 220. The number of treated pluripotent stem cells and the number of cells of the secondary acclimation-treated pluripotent stem cells) can be input via the operation of the administrator.
 以上のとおり、一実施形態に係る馴化細胞管理装置100及びこれを含む管理システム1は、馴化処理に供される多能性幹細胞の情報、馴化された多能性幹細胞の情報、馴化処理そのものの情報等のような様々な情報を取得することで馴化処理を適切に管理、監視することができる。これにより、提供先(顧客)に対して、高品質且つ再現性の高い馴化された多能性幹細胞を提供することが可能となる。さらに、提供先に対して、馴化された多能性幹細胞を提供するだけに留まらず、これに付随する様々な情報も併せて提供することで、提供先に対して追加的な付加価値を提供することが可能となる。 As described above, the acclimatized cell management device 100 and the management system 1 including the acclimatized cell management device 100 according to the embodiment include information on the pluripotent stem cells subjected to the acclimatization process, information on the acclimatized pluripotent stem cells, and the acclimatization process itself. By acquiring various information such as information, the habituation process can be appropriately managed and monitored. This makes it possible to provide high-quality and highly reproducible acclimatized pluripotent stem cells to the recipient (customer). Furthermore, by not only providing acclimatized pluripotent stem cells to the recipients, but also providing various information associated with them, we provide additional value to the recipients. It becomes possible to do.
 また、前述の管理システム1においては、必ずしも馴化細胞管理装置100と馴化処理装置200とを物理的に同じ場所(敷地)内に配置する必要はない。つまり、馴化処理装置200の馴化処理を、遠隔にある馴化細胞管理装置100にて管理、監視することも可能である。したがって、例えば、馴化処理装置200を提供先に貸与して、実際の馴化処理は当該提供先が実行しつつ、その馴化処理を馴化処理装置200の管理者が遠隔で管理、監視(又は必要に応じてサポート)することも可能となる。 Further, in the above-mentioned management system 1, the acclimation cell management device 100 and the acclimation processing device 200 do not necessarily have to be physically arranged in the same place (site). That is, it is also possible to manage and monitor the acclimation process of the acclimation processing device 200 by the remote acclimation cell management device 100. Therefore, for example, the acclimatization processing device 200 is lent to the provider, and the actual acclimatization process is executed by the provider, while the administrator of the acclimatization processing device 200 remotely manages, monitors (or needs) the acclimatization process. It will also be possible to provide support).
 本出願は、以下の日本国特許出願に基づくものであって、当該日本国特許出願による優先権の利益を享受するものである。また、以下の日本国特許出願の全体の内容が参照により本明細書に組み入れられる。
(1)「馴化細胞作製方法」と題して2019年8月20日に提出された日本国特許出願第2019-150483
This application is based on the following Japanese patent application and enjoys the priority of the Japanese patent application. In addition, the entire contents of the following Japanese patent application are incorporated herein by reference.
(1) Japanese Patent Application No. 2019-150483 submitted on August 20, 2019, entitled "Method for Producing Acclimated Cells"
 本明細書に記載されたすべての文献、特許出願、及び技術規格は、参照によりその全体が本明細書に組み入れられる。 All documents, patent applications, and technical standards described herein are incorporated herein by reference in their entirety.

Claims (29)

  1.  平面培養された多能性幹細胞を供給元から受領すること、
     受領した多能性幹細胞に対し、平面培養から浮遊培養への移行を可能にするための馴化処理を行うこと、
     前記馴化処理によって、浮遊培養に馴化した多能性幹細胞を得ること、
     得られた馴化済み多能性幹細胞を、提供先からの要求に応じて、指定された提供先に提供すること、
     を含む、馴化細胞作製方法。
    Receiving flat-cultured pluripotent stem cells from a supplier,
    Perform acclimatization treatment on the received pluripotent stem cells to enable the transition from planar culture to suspension culture.
    By the acclimation treatment, pluripotent stem cells acclimated to suspension culture are obtained.
    To provide the obtained conditioned pluripotent stem cells to a designated destination in response to a request from the destination.
    A method for producing acclimated cells, including.
  2.  前記馴化処理が、
     受領した多能性幹細胞を、一次馴化用培地を充填した一次馴化用培養容器にて一次馴化培養を行い、一次馴化済み多能性幹細胞を得る一次馴化処理、及び、
     前記一次馴化済み多能性幹細胞を、二次馴化用培地を充填した浮遊培養用容器にて浮遊培養を行い、浮遊培養に馴化した二次馴化済み多能性幹細胞を得る二次馴化処理、
     を含む、請求項1に記載の馴化細胞作製方法。
    The acclimation process
    The received pluripotent stem cells are subjected to primary acclimation culture in a primary acclimation culture vessel filled with a primary acclimation medium to obtain primary acclimated pluripotent stem cells.
    The primary conditioned pluripotent stem cells are subjected to suspension culture in a suspension culture container filled with a secondary acclimation medium to obtain secondary conditioned pluripotent stem cells acclimated to the suspension culture.
    The method for producing an acclimated cell according to claim 1, which comprises.
  3.  前記馴化処理に供される前の前記多能性幹細胞に関する初期細胞情報、前記一次馴化処理に関する一次馴化処理情報、前記二次馴化処理に関する二次馴化処理情報、前記一次馴化済み多能性幹細胞に関する一次馴化済み多能性幹細胞情報、及び、前記二次馴化済み多能性幹細胞に関する二次馴化済み多能性幹細胞情報からなる群より選択される少なくとも一つの情報を入手すること、
     をさらに含む、請求項2に記載の馴化細胞作製方法。
    Regarding initial cell information about the pluripotent stem cells before being subjected to the acclimation treatment, primary acclimation processing information regarding the primary acclimation treatment, secondary acclimation processing information regarding the secondary acclimation treatment, and the primary acclimated pluripotent stem cells. To obtain at least one information selected from the group consisting of primary conditioned pluripotent stem cell information and secondary habituated pluripotent stem cell information relating to the secondary conditioned pluripotent stem cell.
    The method for producing conditioned cells according to claim 2, further comprising.
  4.  前記初期細胞情報は、前記馴化処理に供される前の前記多能性幹細胞の細胞種に関する情報を少なくとも含む、請求項3に記載の馴化細胞作製方法。 The method for producing an acclimated cell according to claim 3, wherein the initial cell information includes at least information on the cell type of the pluripotent stem cell before being subjected to the acclimation treatment.
  5.  前記一次馴化処理情報は、前記一次馴化用培地に関する情報、及び前記一次馴化処理に関する培養条件に関する情報を少なくとも含む、請求項3に記載の馴化細胞作製方法。 The acclimated cell preparation method according to claim 3, wherein the primary acclimation treatment information includes at least information on the primary acclimation medium and information on culture conditions related to the primary acclimation treatment.
  6.  前記二次馴化処理情報は、前記二次馴化用培地に関する情報、及び前記二次馴化処理に関する浮遊培養条件に関する情報を少なくとも含む、請求項3に記載の馴化細胞作製方法。 The acclimated cell preparation method according to claim 3, wherein the secondary acclimation treatment information includes at least information on the secondary acclimation medium and information on suspension culture conditions related to the secondary acclimation treatment.
  7.  前記一次馴化済み多能性幹細胞情報は、前記一次馴化済み多能性幹細胞の細胞数、及び細胞形態の特徴に関する情報を少なくとも含み、
     前記二次馴化済み多能性幹細胞情報は、前記二次馴化済み多能性幹細胞の細胞数、及び細胞形態の特徴に関する情報を少なくとも含む、請求項3に記載の馴化細胞作製方法。
    The primary conditioned pluripotent stem cell information includes at least information on the cell number and cell morphological characteristics of the primary conditioned pluripotent stem cells.
    The method for producing an acclimated cell according to claim 3, wherein the secondary acclimated pluripotent stem cell information includes at least information on the number of cells of the secondary acclimated pluripotent stem cell and the characteristics of cell morphology.
  8.  前記初期細胞情報、前記一次馴化処理情報、前記二次馴化処理情報、前記一次馴化済み多能性幹細胞情報、及び前記二次馴化済み多能性幹細胞情報からなる群より選択される少なくとも一つの入手された情報を前記提供先に提供すること、
     をさらに含む、請求項3~請求項7のいずれか一項に記載の馴化細胞作製方法。
    At least one acquisition selected from the group consisting of the initial cell information, the primary acclimation processing information, the secondary acclimation processing information, the primary acclimated pluripotent stem cell information, and the secondary acclimation pluripotent stem cell information. To provide the provided information to the above-mentioned destination,
    The method for producing an conditioned cell according to any one of claims 3 to 7, further comprising.
  9.  前記馴化済み多能性幹細胞は、浮遊培養形態で前記提供先に提供される、請求項1~請求項8のいずれか1項に記載の馴化細胞作製方法。 The method for producing an acclimated cell according to any one of claims 1 to 8, wherein the acclimated pluripotent stem cell is provided to the donor in a suspension culture form.
  10.  コンピュータにより読み取り可能な命令を実行する少なくとも1つのプロセッサにより実行される馴化細胞管理方法であって、
     前記少なくとも1つのプロセッサが、前記命令を実行することにより、
     平面培養された多能性幹細胞に関する初期細胞情報を取得して記憶し、
     前記多能性幹細胞に対し、平面培養から浮遊培養への移行を可能にするための馴化処理に関する馴化処理情報を取得して記憶し、
     前記馴化処理によって生成される馴化済み多能性幹細胞に関する馴化済み多能性幹細胞情報を取得して記憶する、馴化細胞管理方法。
    A method of acclimatization cell management performed by at least one processor that executes computer-readable instructions.
    When the at least one processor executes the instruction,
    Acquire and store early cell information about planar cultured pluripotent stem cells,
    For the pluripotent stem cells, the acclimatization process information regarding the acclimatization process for enabling the transition from the planar culture to the suspension culture is acquired and stored.
    A method for managing acclimated cells, which acquires and stores acclimated pluripotent stem cell information regarding the acclimated pluripotent stem cells generated by the acclimation process.
  11.  前記少なくとも1つのプロセッサは、前記命令を実行することにより、さらに、
     前記馴化済み多能性幹細胞が提供される提供先の、前記馴化済み多能性幹細胞に対する要求に関する提供先要求情報を予め取得して記憶し、
     前記提供先要求情報と前記馴化済み多能性幹細胞情報とを比較して、両者間に相違があるか否かを判定する、請求項10に記載の馴化細胞管理方法。
    By executing the instruction, the at least one processor further
    The destination request information regarding the request for the conditioned pluripotent stem cell of the destination to which the conditioned pluripotent stem cell is provided is acquired and stored in advance.
    The conditioned cell management method according to claim 10, wherein the provided destination request information is compared with the acclimated pluripotent stem cell information to determine whether or not there is a difference between the two.
  12.  前記少なくとも1つのプロセッサは、前記命令を実行することにより、さらに、
     前記初期細胞情報、前記馴化処理情報、及び前記馴化済み多能性幹細胞情報からなる群より選択される少なくとも一つの情報を、通信回線を介して、前記馴化済み多能性幹細胞が提供される提供先の提供先サーバ装置に送信する、請求項10又は請求項11に記載の馴化細胞管理方法。
    By executing the instruction, the at least one processor further
    Provided by which the acclimated pluripotent stem cell is provided with at least one information selected from the group consisting of the initial cell information, the acclimation processing information, and the acclimated pluripotent stem cell information via a communication line. The conditioned cell management method according to claim 10 or 11, which is transmitted to the destination server device.
  13.  前記初期細胞情報、前記馴化処理情報、及び前記馴化済み多能性幹細胞情報は、前記馴化処理を実行する馴化処理装置から通信回線を介して取得される、請求項10~請求項12のいずれか一項に記載の馴化細胞管理方法。 Any of claims 10 to 12, wherein the initial cell information, the acclimation processing information, and the acclimated pluripotent stem cell information are acquired from the acclimation processing device that executes the acclimation processing via a communication line. The conditioned cell management method according to paragraph 1.
  14.  前記提供先要求情報は、前記提供先の提供先サーバ装置から通信回線を介して取得される、請求項11に記載の馴化細胞管理方法。 The acclimatization cell management method according to claim 11, wherein the provision destination request information is acquired from the provision destination server device of the provision destination via a communication line.
  15.  前記馴化処理は、
     前記多能性幹細胞を、一次馴化用培地を充填した一次馴化用培養容器にて一次馴化培養を行い、一次馴化済み多能性幹細胞を得る一次馴化処理、及び、
     前記一次馴化済み多能性幹細胞を、二次馴化用培地を充填した浮遊培養用容器にて浮遊培養を行い、浮遊培養に馴化した二次馴化済み多能性幹細胞を得る二次馴化処理、を含み、
     前記馴化処理情報は、前記一次馴化処理に関する一次馴化処理情報、及び、前記二次馴化処理に関する二次馴化処理情報を含み、
     前記馴化済み多能性幹細胞情報は、前記一次馴化済み多能性幹細胞に関する一次馴化済み多能性幹細胞情報、及び、前記二次馴化済み多能性幹細胞に関する二次馴化済み多能性幹細胞情報を含む、請求項10~請求項14のいずれか一項に記載の馴化細胞管理方法。
    The acclimation process
    The pluripotent stem cells are subjected to primary acclimation culture in a primary acclimation culture vessel filled with a primary acclimation medium to obtain primary acclimated pluripotent stem cells.
    The primary conditioned pluripotent stem cells are subjected to suspension culture in a suspension culture container filled with a secondary acclimation medium, and a secondary acclimation treatment for obtaining secondary conditioned pluripotent stem cells acclimated to the suspension culture is performed. Including
    The acclimation processing information includes primary acclimation processing information regarding the primary acclimation processing and secondary acclimation processing information regarding the secondary acclimation processing.
    The conditioned pluripotent stem cell information includes the primary conditioned pluripotent stem cell information regarding the primary conditioned pluripotent stem cell and the secondary conditioned pluripotent stem cell information regarding the secondary conditioned pluripotent stem cell. The conditioned cell management method according to any one of claims 10 to 14, which comprises.
  16.  前記初期細胞情報は、前記多能性幹細胞の細胞種に関する情報を少なくとも含む、請求項10~請求項15のいずれか一項に記載の馴化細胞管理方法。 The conditioned cell management method according to any one of claims 10 to 15, wherein the initial cell information includes at least information on the cell type of the pluripotent stem cell.
  17.  前記一次馴化処理情報は、前記一次馴化用培地に関する情報、及び前記一次馴化処理に関する培養条件に関する情報を少なくとも含む、請求項15に記載の馴化細胞管理方法。 The conditioned cell management method according to claim 15, wherein the primary acclimation treatment information includes at least information on the primary acclimation medium and information on culture conditions related to the primary acclimation treatment.
  18.  前記二次馴化処理情報は、前記二次馴化用培地に関する情報、及び前記二次馴化処理に関する浮遊培養情報に関する情報を少なくとも含む、請求項15に記載の馴化細胞管理方法。 The acclimation cell management method according to claim 15, wherein the secondary acclimation treatment information includes at least information on the secondary acclimation medium and information on suspension culture information on the secondary acclimation treatment.
  19.  前記一次馴化済み多能性幹細胞情報は、前記一次馴化済み多能性幹細胞の細胞数、及び細胞形態の特徴に関する情報を少なくとも含み、
     前記二次馴化済み多能性幹細胞情報は、前記二次馴化済み多能性幹細胞の細胞数、及び細胞形態の特徴に関する情報を少なくとも含む、請求項15に記載の馴化細胞管理方法。
    The primary conditioned pluripotent stem cell information includes at least information on the cell number and cell morphological characteristics of the primary conditioned pluripotent stem cells.
    The conditioned cell management method according to claim 15, wherein the secondary conditioned pluripotent stem cell information includes at least information on the cell number and cell morphological characteristics of the secondary conditioned pluripotent stem cells.
  20.  1又は複数のプロセッサを具備し、
     該プロセッサが、
     平面培養された多能性幹細胞に関する初期細胞情報を取得して記憶し、
     前記多能性幹細胞に対し、平面培養から浮遊培養への移行を可能にするための馴化処理を行う馴化処理に関する馴化処理情報を取得して記憶し、
     前記馴化処理によって生成される馴化済み多能性幹細胞に関する馴化済み多能性幹細胞情報を取得して記憶する、
     ように前記少なくとも1つのプロセッサを機能させる馴化細胞管理装置。
    Equipped with one or more processors
    The processor
    Acquire and store early cell information about planar cultured pluripotent stem cells,
    Acquire and store the acclimation process information regarding the acclimation process for performing the acclimation process to enable the transition from the planar culture to the suspension culture for the pluripotent stem cells.
    Acquires and stores the acclimated pluripotent stem cell information regarding the acclimated pluripotent stem cell generated by the acclimation process.
    An acclimatized cell management device that causes the at least one processor to function as described above.
  21.  前記馴化済み多能性幹細胞が提供される提供先の、前記馴化済み多能性幹細胞に対する要求に関する提供先要求情報を予め取得して記憶し、
     前記提供先要求情報と前記馴化済み多能性幹細胞情報とを比較して、両者間に相違があるか否かを判定する、
     ように前記少なくとも1つのプロセッサをさらに機能させる、請求項20に記載の馴化細胞管理装置。
    The donor request information regarding the request for the conditioned pluripotent stem cell of the donor to which the conditioned pluripotent stem cell is provided is acquired and stored in advance.
    The destination request information is compared with the acclimatized pluripotent stem cell information to determine whether or not there is a difference between the two.
    The conditioned cell management device according to claim 20, wherein the at least one processor is further functioned as described above.
  22.  前記初期細胞情報、前記馴化処理情報、及び前記馴化済み多能性幹細胞情報からなる群より選択される少なくとも一つの情報を、通信回線を介して、前記馴化済み多能性幹細胞が提供される提供先の提供先サーバ装置に送信する、
     ように前記少なくとも1つのプロセッサをさらに機能させる、請求項20又は請求項21に記載の馴化細胞管理装置。
    Provided that the acclimated pluripotent stem cell is provided with at least one information selected from the group consisting of the initial cell information, the acclimation processing information, and the acclimated pluripotent stem cell information via a communication line. Send to the destination server device,
    The acclimated cell management device according to claim 20 or 21, wherein the at least one processor further functions as described above.
  23.  前記初期細胞情報、前記馴化処理情報、及び前記馴化済み多能性幹細胞情報は、前記馴化処理を実行する馴化処理装置から通信回線を介して取得される、請求項20~請求項22のいずれか一項に記載の馴化細胞管理装置。 Any of claims 20 to 22, wherein the initial cell information, the acclimation processing information, and the acclimated pluripotent stem cell information are acquired from the acclimation processing device that executes the acclimation processing via a communication line. The acclimated cell management device according to paragraph 1.
  24.  前記提供先要求情報は、前記提供先の提供先サーバ装置から通信回線を介して取得される、請求項21に記載の馴化細胞管理装置。 The acclimatized cell management device according to claim 21, wherein the provider request information is acquired from the provider server device of the provider via a communication line.
  25.  少なくとも1つのプロセッサにより実行されることにより、
     平面培養された多能性幹細胞に関する初期細胞情報を取得して記憶し、
     前記多能性幹細胞に対し、平面培養から浮遊培養への移行を可能にするための馴化処理を行う馴化処理に関する馴化処理情報を取得して記憶し、
     前記馴化処理によって生成される馴化済み多能性幹細胞に関する馴化済み多能性幹細胞情報を取得して記憶する、
     ように前記少なくとも1つのプロセッサを機能させる、コンピュータプログラム。
    By running on at least one processor
    Acquire and store early cell information about planar cultured pluripotent stem cells,
    Acquire and store the acclimation process information regarding the acclimation process for performing the acclimation process to enable the transition from the planar culture to the suspension culture for the pluripotent stem cells.
    Acquires and stores the acclimated pluripotent stem cell information regarding the acclimated pluripotent stem cell generated by the acclimation process.
    A computer program that activates at least one processor as described above.
  26.  前記馴化済み多能性幹細胞が提供される提供先の、前記馴化済み多能性幹細胞に対する要求に関する提供先要求情報を予め取得して記憶し、
     前記提供先要求情報と前記馴化済み多能性幹細胞情報とを比較して、両者間に相違があるか否かを判定する、
     ように前記少なくとも1つのプロセッサをさらに機能させる、請求項25に記載のコンピュータプログラム。
    The donor request information regarding the request for the conditioned pluripotent stem cell of the donor to which the conditioned pluripotent stem cell is provided is acquired and stored in advance.
    The destination request information is compared with the acclimatized pluripotent stem cell information to determine whether or not there is a difference between the two.
    25. The computer program of claim 25, which further causes the at least one processor to function.
  27.  前記初期細胞情報、前記馴化処理情報、及び前記馴化済み多能性幹細胞情報からなる群より選択される少なくとも一つの情報を、通信回線を介して、前記馴化済み多能性幹細胞が提供される提供先の提供先サーバ装置に送信する、
     ように前記少なくとも1つのプロセッサをさらに機能させる、請求項25又は請求項26に記載のコンピュータプログラム。
    Provided that the acclimated pluripotent stem cell is provided with at least one information selected from the group consisting of the initial cell information, the acclimation processing information, and the acclimated pluripotent stem cell information via a communication line. Send to the destination server device,
    25. The computer program according to claim 25 or 26, which further functions the at least one processor as described above.
  28.  前記初期細胞情報、前記馴化処理情報、及び前記馴化済み多能性幹細胞情報は、前記馴化処理を実行する馴化処理装置から通信回線を介して取得される、請求項25~請求項27のいずれか一項に記載のコンピュータプログラム。 Any of claims 25 to 27, wherein the initial cell information, the acclimatization processing information, and the acclimatized pluripotent stem cell information are acquired from the acclimatization processing apparatus that executes the acclimatization processing via a communication line. The computer program described in paragraph 1.
  29.  前記提供先要求情報は、前記提供先の提供先サーバ装置から通信回線を介して取得される、請求項26に記載のコンピュータプログラム。 The computer program according to claim 26, wherein the provision destination request information is acquired from the provision destination server device of the provision destination via a communication line.
PCT/JP2020/031310 2019-08-20 2020-08-19 Method for producing habituated cells, method for managing habituated cells, device for managing habituated cells, and computer program WO2021033722A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019150483A JP2022158092A (en) 2019-08-20 2019-08-20 Method for manufacturing conditioned cell
JP2019-150483 2019-08-20

Publications (1)

Publication Number Publication Date
WO2021033722A1 true WO2021033722A1 (en) 2021-02-25

Family

ID=74660945

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2020/031310 WO2021033722A1 (en) 2019-08-20 2020-08-19 Method for producing habituated cells, method for managing habituated cells, device for managing habituated cells, and computer program

Country Status (2)

Country Link
JP (1) JP2022158092A (en)
WO (1) WO2021033722A1 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008546410A (en) * 2005-06-22 2008-12-25 ジェロン・コーポレーション Suspension culture method of human embryonic stem cells
JP2015100309A (en) * 2013-11-25 2015-06-04 東京エレクトロン株式会社 Automatic culture system and cell management system
JP2018022456A (en) * 2016-08-04 2018-02-08 ファナック株式会社 Ips cell banking system utilizing internet technology and method thereof
JP2018022457A (en) * 2016-08-04 2018-02-08 ファナック株式会社 Ips cell banking system utilizing medium and method thereof
JP2018019685A (en) * 2016-08-04 2018-02-08 ファナック株式会社 Stem cell production system, stem cell information management system, stem cell transportation facility, and stem cell refrigeration storage facility
JP2019520848A (en) * 2016-07-19 2019-07-25 アクセルタ リミテッドAccellta Ltd. Culture medium for suspension culture of pluripotent stem cells

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008546410A (en) * 2005-06-22 2008-12-25 ジェロン・コーポレーション Suspension culture method of human embryonic stem cells
JP2015100309A (en) * 2013-11-25 2015-06-04 東京エレクトロン株式会社 Automatic culture system and cell management system
JP2019520848A (en) * 2016-07-19 2019-07-25 アクセルタ リミテッドAccellta Ltd. Culture medium for suspension culture of pluripotent stem cells
JP2018022456A (en) * 2016-08-04 2018-02-08 ファナック株式会社 Ips cell banking system utilizing internet technology and method thereof
JP2018022457A (en) * 2016-08-04 2018-02-08 ファナック株式会社 Ips cell banking system utilizing medium and method thereof
JP2018019685A (en) * 2016-08-04 2018-02-08 ファナック株式会社 Stem cell production system, stem cell information management system, stem cell transportation facility, and stem cell refrigeration storage facility

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LIPSITZ, YONATAN Y., WOODFORD CURTIS, YIN TING, HANNA JACOB H., ZANDSTRA PETER W.: "Modulating cell state to enhance suspension expansion of human pluripotent stem cells", PROC NATL ACAD SCI U S A., vol. 115, no. 25, 19 June 2018 (2018-06-19), pages 6369 - 6374, XP055794210, DOI: 10.1073/pnas.1714099115 *

Also Published As

Publication number Publication date
JP2022158092A (en) 2022-10-17

Similar Documents

Publication Publication Date Title
Tamm et al. A comparative study of protocols for mouse embryonic stem cell culturing
Crook et al. The generation of six clinical-grade human embryonic stem cell lines
International Stem Cell Initiative Consortium et al. Comparison of defined culture systems for feeder cell free propagation of human embryonic stem cells
Xu et al. Efficient generation and cryopreservation of cardiomyocytes derived from human embryonic stem cells
Want et al. Large-scale expansion and exploitation of pluripotent stem cells for regenerative medicine purposes: beyond the T flask
EP2173863B1 (en) Automated method and apparatus for embryonic stem cell culture
Stephenson et al. Derivation and propagation of human embryonic stem cell lines from frozen embryos in an animal product–free environment
Ausubel et al. GMP scale-up and banking of pluripotent stem cells for cellular therapy applications
Burridge et al. Highly efficient directed differentiation of human induced pluripotent stem cells into cardiomyocytes
Stover et al. Adaptation of human pluripotent stem cells to feeder-free conditions in chemically defined medium with enzymatic single-cell passaging
Schwartz et al. Traditional human embryonic stem cell culture
Xiang et al. Generation of regionally specified human brain organoids resembling thalamus development
Fuegemann et al. Differentiation of mouse embryonic stem cells into cardiomyocytes via the hanging‐drop and mass culture methods
Tosolini et al. From naive to primed pluripotency: in vitro conversion of mouse embryonic stem cells in epiblast stem cells
Castro-Viñuelas et al. Tips and tricks for successfully culturing and adapting human induced pluripotent stem cells
JP2020503878A (en) Compositions for culturing pluripotent stem cells
Siller et al. Rapid screening of the endodermal differentiation potential of human pluripotent stem cells
Dashtban et al. Addressing manufacturing challenges for commercialization of iPSC-based therapies
WO2021033722A1 (en) Method for producing habituated cells, method for managing habituated cells, device for managing habituated cells, and computer program
Desai et al. Development of a xeno-free non-contact co-culture system for derivation and maintenance of embryonic stem cells using a novel human endometrial cell line
Ilic et al. Derivation of hESC from intact blastocysts
Parr et al. cGMP-compliant expansion of human iPSC cultures as adherent monolayers
Sivarajah et al. The generation of GLP-grade human embryonic stem cell banks from four clinical-grade cell lines for preclinical research
Hunt The banking and cryopreservation of human embryonic stem cells
Moody Feeder-independent culture systems for human pluripotent stem cells

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20855426

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 24.05.22)

NENP Non-entry into the national phase

Ref country code: JP

122 Ep: pct application non-entry in european phase

Ref document number: 20855426

Country of ref document: EP

Kind code of ref document: A1